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As part of the Ex post evaluation of the 2007-2013 programming period of the European 
Cohesion Policy this report deals with the impact of the varying per capita intensities of EU 
funds on regional growth. The works was separated in three tasks. The first one focuses on the 
analysis of how the intensity variation of EU structural funds affected regional growth in the 
EU-15 regions in the 1994-2006 period. Task 2 deals with the impact of EU cohesion policy on 
regional growth in the EU-27 regions. Task 3 is wider because it tackles the analysis of 
cohesion policy effects for all European countries, considering data up to 2013. Thanks to 
statistical methods impacts are estimated. The tasks involved using a counterfactual impact 
evaluation design, implementing with propensity score matching (PSM) and generalized 
propensity score matching (GPSM).  
 
As concerns the Task1 of this project, there were two main objectives of the analysis. A) 
Compare results obtained with a PSM approach to those from earlier RDD analysis research 
(Pellegrini et al. 2013 and Becker et al. 2013) to highlight lessons that can be learned on the 
data availability scenarios that make preferable to use of one method as supposed to the 
other. B). Estimate different impacts for different levels of the per capita intensity of the EUF. 
As mentioned in the technical offer, objective B) of the analysis can be achieved by 
operationalizing the intensity level of the EUF either dichotomously (as implemented in 
Pellegrini et al 2013) or with multiple categories of intensity levels (in discrete or continuous 
terms, as implemented, at the NUTS3 level, in Becker et al. 2013). To enhance comparability 
with the RDD work package, and because of serious reliability issues with the NUTS3 level 
data, it was agreed with DG-regio to use NUTS2 level as the units of observation of the 
analysis, instead of the NUTS3 level used by in Becker et al. 2013. Because of the choice to 
focus on NUTS2 regions as units of observation, the overall sample size of the regions with 
comparable pre-intervention characteristics is not large enough (at the EU15 level for the 
1994-2006 period) to allow statistically significant estimations of a continuous or categorical 
dose-response function. For this reason the Task 1 analyses presented in this report is 
implemented entirely within the framework of the dichotomous difference in the degree of 
intensity of the EUF adopted in Pellegrini et al 2013 (i.e. a binary treatment status variables 
that distinguishes the higher per capita intensity of the EUF related with “Obj.1”/“Convergence 
Obj” eligibility from the lower per-capita intensity related with the “non-Obj.1/Convergence 
Obj.1 eligibility”). Thus, as indicated in the technical offer, the actual data availability scenario 
and sample size considerations dictated the choice of the exact model that was used in the 
Task 1 analysis.  
Generalised Propensity Score Matching and propensity score matching estimators with multiple 
categorical treatment status variables for the different intensities of the EUF were instead 
applied to the analysis for the Tasks 2 and 3 of this projects. These tasks involve estimating 
how varying per capita intensity of EUF affected regional growth, extending the analysis of 
Task 1 to include the larger sample of EU-27 regions over the period 1994-2013 and 
considering a larger number of outcome variables to include, employment growth and growth 
of (per capita) gross fixed capital formation, in addition to the per capita regional growth of 
GDP used in Task 11.  
  
                                                          
1 As mentioned in the technical offer, the list of outcome variables used for the analysis has been 
determined in agreement with DG-Regio based on the actual data availability for the entire list of NUTS2 
regions considered in the analysis. 





1. RDD vs Matching for Regional-Level CIEs of  EU Funds (EUF) 
When adopting RDD for regional-level CIEs of structural and cohesion fund programmes, the 
following considerations apply: 
• The units of observation for the analysis (i.e. the EU regions) did not self-selected into 
applicants and non-applicant for obtaining the former Obj.1 / Convergence Obj status: 
such eligibility was based, by the most part on the GNI in PPS recorded by Eurostat. For 
this reason,  no obvious advantage of RDD versus other CIE methods exist  due to the fact 
that in RDD the treated units can be compared only with untreated units with the same 
initial desire to be treated (while, with other CIE methods, the treated units can be 
potentially compared with a general population of non-treated units, regardless of whether 
or not they participated into the program application process). Thus applying RRD versus 
other CIE methods does not guarantee any better controlling of the unobservable 
confounding factors (i.e factors affecting the outcome variable a part from the treatment) 
leading to the same desire to be treated. 
• In set ups suitable for RDD, the more the forcing variable (determining the treatment 
status of the units of observations) is a factor with a weak influence on the outcome 
variable Y of the analysis (i.e. a “non-dominant” forcing variable), the more the treatment 
assignment process  mimic an actual randomization also away from the cut-off point.  This 
bears an important consequence: The more the forcing variable does not constitute a 
“dominant” confounding factor, the larger is the band across the cut-off point in which 
conditions similar to a randomized experiment apply. 
• Since RDD mimics a block randomization within the neighbourhoods of the cut-off point, in 
the presence of small samples and of a “non-dominant” forcing variable, it has to checked 
whether or not the sample of treated and non-treated units in the neighbourhood of  the 
cut-off point are indeed balanced with regards to the other relevant confounding factors 
(different from the forcing variable). As widely discussed in the literature, this is common 
wisdom in the field of randomized experiments:  with small samples, unbalanced 
compositions can happen and the randomization process has to be repeated or 
implemented as block randomization with regards to all the major confounding factors. 
• In the presence of small samples, the more “dominant” is the forcing variable, the less it is 
necessary to check whether or not the treated and non-treated units in the neighbourhood 
of the cut-off are balanced with regard to other confounding factors (this is because similar 
levels of a “dominant” forcing variable ensure per-se an overall balance between treated 
and non-treated units even in the presence of small samples).  When the sample size is 
small, the more the forcing variable is a weak confounding factor (“non-dominant”), the 
more it has to checked whether or not the treated and non-treated units in the 
neighbourhood of the cut-off are indeed balanced with regard to the actual major 
confounding factors (which are different from the forcing variable) 
In the case of the EU regions, for the 1994-1999 period, the forcing variable to determine 
Obj.1 eligibility was the per-capita GNI in terms of PPS recorded by Eurostat in 1988-1990 , 
which is almost 6 years before the start of the implementation of any actual subsidized Ob.1 
project. Similar large temporal gaps were in existence also for the 2000-06 and 2007-13 
programming periods, with the eligibility to the higher intensities of EU funds –EUF- (i.e. 




Objective 1/Convergence Objective area eligibility) based on a forcing variable measured in 
1994-96 and 2000-02 respectively. Because of such large temporal gaps and because the 
forcing variable measures GDP levels while the outcome variables of the analysis are in terms 
of regional growth, it can be deemed that the forcing variable is not a confounding factor that 
capture all the relevant regional characteristics that may affect the outcome variables Y used in 
the analysis.  
Moreover, the sample size of the regions that can be found near the cut-off is very small. Thus, 
in light of the arguments discussed above, the treated and non-treated units positioned only 
sharply in the neighbourhood of the cut-off are guaranteed to be balanced only with respect to 
the forcing variable. Because of the small sample size of the regions in the neighbourhood of 
such cut-off, no guarantee is offered with regard of the actual balancing of other important 
regional characteristic that influence the outcome Y (in the same way as no balancing is 
guaranteed with small samples even with actual randomization). 
Thus, with small sample sizes, forcing the comparison to only the regions sharply across the 
cut-off point (compared to other CIE methods such as matching) may prevent balancing to 
occur with respect to the other important regional characteristics that are important risk 
factors for selection bias. In other word, enlarging the neighbourhood across the cut-off of the 
forcing variable and ensuring statistical matching between treated and non-treated regions, 
may achieve a better overall balancing of all  the confounding factors compared to a standard 
sharp RDD design.  If the forcing variable has the same (or lower)  importance as a 
confounding factor as other regional characteristics, thus, a best overall balancing between 
treated and non-treated regions could be achieved ensuring a good matching of all confounding 
factors (i.e. using matching estimators), rather than with standard RDD in which an exact 
matching occurs only for the forcing variable and (due to the small sample size) no guarantee 
is offered with regard to the actual balancing of other important confounding factors.   
 
  




2. Data (Task 1) 
The sources of the data used in the analysis are as follows: 
• Outcome variable (Y): As mentioned in the ToR and in the Technical Offer, to enhance 
result comparability, the analysis exploits the same GDP data used in the RDD study of 
Pellegrini et. al (2012). Such GDP data were made available to the analysis directly by the 
authors of that study and the sources they mentioned for the data are DG-Regio for 1995-
1999 and Eurostat for the period 2000-2006. The outcome variable used for the analysis is 
operationalized as the average per-capita annual GDP growth; 
• Treatment status variable (T): based on the figures from DG-Regio on the EUF 
allocated at the NUTS2 level, the different per-capita intensity of EUF has been coded 
dichotomously in the following way: 
Ti=1 if a NUTS2 i has the additional per-capita EUF availability typically associated with 
Obj1 (convergence Obj.) eligibility (“hard financed regions”). The threshold for 
operationalizing such “hard financed” regions is, following Pellegrini et al. (2013) 
a minimum total value of EUF of 1960 Euro per head2. 
Ti=0  if a a NUTS2 i does not have the additional per-capita EUF associated with Obj1 
(convergence Obj.) eligibility (“soft financed regions”); 
 
• Control variables (X): the control variables used in the analysis to ensure good 
balancing between the treatment (Ti=1) and the comparison group (Ti=0) were 
constructed based on the following 1991-1994 yearly data provided at the NUTS2 level by 
Cambridge Econometrics: 
o GDP;  
o employment rate;  
o per capita worker compensation; 
o gross fixed capital formation; 
o labour productivity (GDP per worker). 
These yearly NUTS2 data were used to operationalize two sets of control variables: 
Xgrw = set of yearly growth rates of the control variables X, operationalized as 
yearly percentage changes; 
Xlev = set of average levels of the control variables X, operationalized as yearly 
average level of X over the period 1991-1994; 
• Forcing variable (Z): for the purpose of comparing the PSM results with those of the 
RDD analysis, the Obj.1 area eligibility variable (Z) was also considered in the analysis. 
Such variable (Z), referred to as the “forcing variable” is the average per capita GDP of the 
NUTS2 regions during the 1988-1990 period, in term of purchasing power standards (PPS). 
  
                                                          
2 To enhance result comparability, we adopted such dichotomous operationalization  of the treatment 
status variable based on the same data on the regional EU funds allocation used in Pellegrini et. al 2013. 
The data that were provided to us for the analysis did not include the exact figures of the 1995-2006 EU 
funds expenditures sorted by NUTS2 regions. Further details on the matter can be found in Pellegrini et. 
al 2013. 




3. Caveats and limitations of the data (Task 1) 
The data availability scenario described in the previous section poses the following limitations 
to the analysis: 
• The pre-intervention control variables X available for the analysis are measured in the 
1991-1994 period which is right before the beginning of the 1995-2006 period of 
observation of the EUF expenditures under evaluation. This solution is standard practice in 
the literature and it is adopted, for example, in the Generalized Propensity Score –GPS- 
study of Backer et al. (2013). However, a large group of NUTS2 regions of Spain and 
southern Italy, five NUTS2 regions of France (Corsica and the outer territories) in addition 
of the whole group of NUTS2 of Greece and Ireland received Obj.1 EUF assistance from the 
1989-1993 programming period that could have potentially affected the GDP growth in the 
1991-1994 period. The Obj.1 EUF assistance for the 1989-1993 programming period 
amounted to 13 Billion Euro for Greece, 9.75 Billion Euro for Spain, 1 Billion for France, 4.1 
Billion for Ireland and  8.4 Billion for Italy. For Spain and Italy, however, deadline 
extensions and amendments of Operational Programmes were granted until the end of 
1994 (source: Fifth annual report on the implementation of the reform of the structural 
funds, 19933). Such deadline extensions and re-programming resulted in an actual the 
implementation of the Obj.1 subsidized projects that took part, by the most part not 
before the end of 1994. An actual completion of the funded projects and initiatives beyond 
the end of the 1989-1993 programming period is also documented for the Obj.1 regions 
Ireland, Greece and France. For this reason it can be deemed that the presence of the 
1989-1993 EUF devoted to the Obj.1 regions had little chances to have heavily affected 
the regional GDP growth (and other control variables) before 1994.  
 
• In empirical studies that investigates at the NUTS2 level the causality links between 
regional characteristics and future economic growth, some additional covariates were 
found to be good predictors of future GDP growth. Such predictors were, for example, the 
percentage of  residents with high educational attainments. These variables, were not 
available for the analysis at the moment in which task 1 was implemented, but they are 
included in the control variables used for Task2 and Task3 (in Part II of this report) 
 
  
                                                          
3 http://aei.pitt.edu/4011/1/4011.pdf 




4. Sample sizes and descriptive statistics (Task 1) 
The 1995-2006 GDP data made available to the analysis contained information on 213 NUTS 2 
regions in the EU 15 area. 61 of such regions were eligible for the additional support related to 
Obj.1 (conv. Obj.) eligibility and 152 regions were not eligible for the additional Obj.1 
(convergence Obj,) support.  
To ensure result comparability, as specifically required in the ToR, from such group of 213 
NUTS2 regions, we operated the same exclusions as in Pellegrini et al (2013): 
• -Four regions where excluded because their level of per capita GDP in the period 1988–
1990 (i.e., the reference period for the determination of Objective 1 eligibility by the 
European Commission) was above 75 per cent of EU average [these regions are: Prov. 
Hainaut (BE), Corse (FR), Molise(IT), Lisboa (PT)]; 
• -Ten regions were excluded because they were not Obj. 1 in the 1994–1999 period but 
turned out to be eligible (or partially eligible) for Objective 1 funds in the 2000–2006 
period: Burgenland (AT), Itä-Suomi (FI), South Yorkshire (UK), Cornwall and Isles of Scilly 
(UK), West Wales and The Valleys (UK); Länsi-Suomi (FI), Pohjois-Suomi (FI), Norra 
Mellansverige (SE), Mellersta Norrland (SE), Övre Norrland (SE); 
• -Nine regions were excluded from the comparison group of “soft-financed” non-Obj.1  
regions because, considering all the different sources of EUF financing in the two 
programming periods, they received a total per-capita aid intensity greater than the 
minimum threshold (1960 Euro per head) recorded for the actual Obj.1 (Convergence Obj) 
regions. These regions are seven NUTS2 from Spain (Pais Vasco, Comunidad Foral de 
Navarra, La Rioja, Aragón, Comunidad de Madrid, Cataluña, IllesBalears) and two NUTS2 
from Finland (Etelä-Suomi, Åland); 
In order to successfully merge the 1995-2006 GDP annual series (which adopted the NUTS2 
2003 code definition) with the 1991-1994 control variable data (that adopted a more recent 
NUTS2 code definition), the following additional changes were required compared to the GDP 
series of Pellegrini et al. (2013): 
• Two NUTS2 regions of Germany, DE40 and DE41 (in the pre-2003 code definition) had to 
be me merged into one NUTS2 code (DE40  Brandenburg); 
• Three (pre-2003) NUTS2 regions of Germany (DEE1 Dessau, DEE2 Halle, DEE3 
Magdeburg) had to be merged into the single NUTS2 region of Sachsen-Anhalt (DEE0). 
 
4.1 Sample sizes of NUTS2 regions available for the analysis 
 
Table 1 describes the final sample size of the groups of NUTS2 regions available for the 
analysis, sorted into Obj.1 regions and non-Obj.1 regions. 
  





Table 1 : Sample sizes of NUTS2 regions by Eligibility Status (T=1 Obj.1; T=0 non-Obj.1) 
          T |      Freq.     Percent   
------------+------------------------- 
          0 |        133       71.12   
          1 |         54       28.88   
------------+------------------------- 
      Total |        187      100.00 
 
To draw comparisons between the results of this study and the RDD results, in Tables 2-4 are 
reported the sample sizes of the Obj.1 and non-Obj.1 regions sorted based on their value of 
the “forcing variable” (Z)  for Obj.1 (Convergence Obj,) eligibility. Table 2 displays the sample 
sizes of the NUTS2 regions with a value of Z within +/- ¼ of the Standard Deviation (SD) away 
from the cut-off point [i.e. with values of Z  between  67.85% of the EU average (=75-7.15) 
and 82.15% (75+7.15)].  
 
Table 2 : Sample sizes of NUTS2 regions within ¼ SD from cut-off of Z (67.85% <Z >82.15%) 
          T |      Freq.     Percent   
------------+------------------------- 
          0 |         13       50.00   
          1 |         13       50.00   
------------+------------------------- 
      Total |         26      100.00 
 
Table 3 illustrates the sample sizes of the regions with Z within ½ SD away from the cut-off 
point (i.e. with values of Z between 60.70% and 89.30%). 
Table 3 : Sample sizes of NUTS2 regions within 1/2 SD from cut-off of Z (60.70% <Z >89.30%) 
          T |      Freq.     Percent   
------------+------------------------- 
          0 |         37       60.66   
          1 |         24       39.24   
------------+------------------------- 
      Total |         61      100.00 
 
 
4.2 Descriptive statistics on the balance of the pre-intervention covariates 
(X) between Obj.1 and non-Obj.1 regions 
 
In order to draw comparisons between the PSM and the RDD results, it is useful to investigate 
how the pre-intervention (1991-1994) characteristics of the Obj1. and non-Obj.1 regions are 
balanced. This is done separately for the set of Xgrw (control variables in terms of pre-
intervention growth) and of Xlev (control variables in terms of average pre-intervention levels) 








a) regions with values of Z just above or the below the cut-off (i.e. within  ¼ SD away 
from the cut-off);  
b) regions with values of Z +/- ½ SD from the cut-off;  
c) regions with any values of Z (i.e. the whole sample of regions). 
The figures reported in Table 4 shows that for the growth rate pre-intervention covariates, the 
overall balance between the Obj.1 regions (treated) and the non-Obj.1 regions (control) does 
not improve much by restricting the sample of NUTS2 to only the regions with similar values of 
the “forcing variable” Z (sample A), as supposed to whole sample of regions (C).  Such finding 
is consistent with the hypothesis that the “forcing variable “(Z) that does not capture all the 
relevant pre-intervention growth-trends controls that may represent risk-factors for selection  
 
Table 4 : Pre-intervention differences in Xgrw between Obj.1 (treated) and non-Obj.1 regions (control) 
                        |       Mean               |     t-test    
Variable                | Treated Control    %bias |    t    p>|t| 
------------------------+--------------------------+-------------- 
A) Regions with Z within  1/4 SD away from the cut-off 
d_emprate               |-1.3534  -1.3031     -3.2 |  -0.08  0.935 
d_compens               |-.24538   1.8341    -86.7 |  -2.21  0.037 
d_grsfixcapt            |-1.4274  -.83096    -15.5 |  -0.39  0.696 
d_GDP                   | 1.1565   1.5455    -28.8 |  -0.74  0.469 
d_labprod               | 2.6028   2.9452    -22.1 |  -0.56  0.579 
------------------------------------------------------------------ 
B) Regions with Z within  1/2 SD away from the cut-off 
d_emprate               |-1.3187  -1.0414    -21.3 |  -0.84  0.406 
d_compens               |-.40011   1.6557    -80.7 |  -3.36  0.001 
d_grsfixcapt            |-2.7986  -.20104    -59.4 |  -2.34  0.023 
d_GDP                   | .52153   1.5145    -67.6 |  -2.67  0.010 
d_labprod               | 1.9545   2.6179    -37.3 |  -1.43  0.159 
------------------------------------------------------------------ 
C) All Regions 
d_emprate               |-.90036  -1.0859     15.1 |   0.98  0.326 
d_compens               | 3.1352     1.24     35.9 |   2.86  0.005 
d_grsfixcapt            | -1.042   .02656    -21.7 |  -1.39  0.166 
d_GDP                   | 1.7761   1.0389     17.7 |   1.36  0.174 
d_labprod               | 2.7872   2.1785     14.0 |   1.08  0.279 
------------------------------------------------------------------ 
 
For what is concerns instead the set of control variables in terms of average pre-intervention 
levels (Table 6), the balance between the treated (Obj.1) and control (non-Obj.1) regions does 
somehow improves by considering solely the NUTS2 areas with similar values of Z (sample A) 
as supposed to the whole sample (C). ).  Such finding is consistent with the hypothesis that the 
“forcing variable “(Z) is somehow correlated solely with the pre-intervention average levels of 
the control variables that may represent risk-factors for selection bias. 
  
 




Table 5 : Pre-intervention differences in Xlev between Obj.1 (treated) and non-Obj.1 regions (control) 
                        |       Mean               |     t-test    
Variable                | Treated Control    %bias |    t    p>|t| 
------------------------+--------------------------+-------------- 
A) Regions with Z within  1/4 SD away from the cut-off 
avg_emprate             | 53.552   59.864    -79.4 |  -2.03  0.054 
avg_compens             |  20073    27294   -174.0 |  -4.44  0.000  
avg_grsfixcapt          | 3370.2   3705.6    -36.0 |  -0.92  0.368  
avg_GDP                 |  16049    19299   -153.7 |  -3.92  0.001  
avg_labprod             |  44844    49933    -73.2 |  -1.87  0.074  
------------------------------------------------------------------ 
B) Regions with Z within  1/2 SD away from the cut-off 
avg_emprate             | 52.289   60.146   -111.2 |  -4.31  0.000  
avg_compens             |  19065    27060   -179.5 |  -7.10  0.000  
avg_grsfixcapt          | 3356.5   3712.3    -28.6 |  -1.03  0.306  
avg_GDP                 |  14945    18970   -213.0 |  -8.30  0.000  
avg_labprod             |  42923    48338    -93.9 |  -3.56  0.001  
------------------------------------------------------------------ 
C) All Regions 
avg_emprate             | 55.002   66.808   -126.2 |  -7.56  0.000  
avg_compens             |  16813    28429   -199.2 | -13.54  0.000  
avg_grsfixcapt          | 3325.6   4167.7    -59.4 |  -3.68  0.000  
avg_GDP                 |  13374    23271   -213.6 | -11.59  0.000  




To further investigate how dominant is the “forcing variable” (Z) in controlling for some pre-
intervention regional covariates that may be linked with future regional growth, we plot each 
value of Z against the corresponding value of each control variable, both in terms of pre-
intervention growth-trends (Figures 1-5) and in terms of pre-intervention average levels 
(figures 6-10). In Figures 1-10, the cut-off point of the “forcing variable” Z (1988-1990 per-
cpaita GDP as a % of EU mean) is indicated with a vertical red line. 
  
 




Figure 1 : Pre-intervention annual % change in the employment rate (1=p.p.) plotted against values of Z 
(per-capita GDP in 1988-90 in terms of % of EU mean) 
 
Figure 2 : Pre-intervention annual % growth in GDP per-capita (1=p.p.) plotted against values of Z (per-
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Figure 3 : Pre-intervention annual % change in worker compensation (1=p.p.) plotted against values of Z 
(per-capita GDP in 1988-90 in terms of % of EU mean) 
 
Figure 4 : Pre-intervention annual % growth in per-capita fixed capital formation (1=p.p.) plotted against 
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Figure 5 : Pre-intervention annual % growth (1=1 p.p.) in labour productivity (GDP per-worker) plotted 
against values of Z (per-capita GDP level in 1988-90 in terms of % of EU mean) 
 
 
The plotted charts of Figures 1-5 illustrates well a lack of a strong correlation between the 
values of the “forcing variable” Z and the pre-intervention growth-rate of the control variables 
used in the analysis. Such lack of correlation does not ensure, in the presence of small 
samples, that an adequate balancing between the pre-intervention growth-trends is achieved 
between the Obj.1 (treated) and non-obj1 (non-treated) regions that have values of the 
“forcing variable” Z close to the cut-off point. 
The plotted charts of Figures 6-10, instead, depict a fairly evident correlation between the 
“forcing variable” Z and the average pre-intervention values of the control variables. Such 
correlation has two important implications for the analysis: 
a) The regions with balanced pre-intervention levels of the control variables across the 
treatment and comparison group, tend to be those with values of Z in the 
neighbourhood of the cut-off point; 
b) The overall number of regions on the common support (i.e. with balanced pre-
intervention characteristics) is drastically reduced when the control variables are 
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Figure 6 : Pre-intervention average level of employment rate (1=1%) plotted against values of Z (per-
capita GDP in 1988-90 in terms of % of EU mean) 
 
 
Figure 7 : Pre-intervention average level of GDP per-capita (1=EUR) plotted against values of Z (per-capita 
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Figure 8 : Pre-intervention average level of worker compensation (1=EUR) plotted against values of Z 
(per-capita GDP in 1988-90 in terms of % of EU mean) 
 
 
Figure 9 : Pre-intervention average level of per-capita fixed capital formation (1=EUR) plotted against 
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Figure 10 : Pre-intervention average level of labour productivity (GDP per-worker, 1=1 EUR) plotted 
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5. Methods:  Propensity Score Matching estimation 
The estimates of the impact of the additional EUF related to Obj.1 eligibility on the 1995-2006 
average per-capita GDP growth have been obtained from the following Propensity Score 
Matching (PSM) models: 
• Radius Matching; 
• Nearest Available Caliper Matching; 
• Kernel Matching. 
5.1 Radius Matching estimators 
 
Radius matching estimators were implemented in the analysis with different values of the 
tolerance radius () and the following different specifications of the control variables:  
• Growth-rate trends (Xgrw) in terms of pre-intervention: employment rate (emplrate); 
worker compensation (wrk_compens), per–capita GDP (GDP), gross fixed capital formation 
(gross_fxd_cap_form) and labour productivity (in terms of GDP per-worker: lab_prod); 
• Three growth-rate trends and three average-level controls (wrk_compens, GDP, 
gross_fxd_cap_form); 
• A full set of controls (Xgrw + Xlev) in terms of pre-intervention both growth-trends and levels 
(emplrate; wrk_compens; GDP; gross_fxd_cap_form; lab_prod). 
 
Formally the estimation procedure entailed the following steps: 
a) Estimation of three different probit specifications: 
P(T=1) =(Xgrw)     (1) or 
P(T=1) =(X6var)    (2) or 
P(T=1) =(Xgrw,  Xlev)   (3)  
Where:  
T=1 receiving the additional EU fund aid intensity related to the Obj.1 area 
designation; 
Xgrw = set of pre-intervention (1991-1994) control variables in terms average 
annual growth-rate trends of: employment rate (emplrate); worker 
compensation (wrk_compens), per–capita GDP (GDP), gross fixed capital 
formation (gross_fxd_cap_form) and labour productivity (in terms of GDP per-
worker: lab_prod); 
X6var = set of six pre-intervention (1991-1994) control variables composed by 
three average annual growth-rate trends and three average annual levels of: 
worker compensation (wrk_compens), per–capita GDP (GDP), gross fixed capital 
formation (gross_fxd_cap_form); 




Xlev= set of pre-intervention (1991-1994) control variables in terms average 
annual levels of: employment rate (emplrate); worker compensation 
(wrk_compens), per–capita GDP (GDP), gross fixed capital formation 
(gross_fxd_cap_form) and labour productivity (in terms of GDP per-worker: 
lab_prod). 
b) The predicted probabilities T^= (X^) from the three probit specifications (1-3) 
represents three sets of Propensity Scores (PS) alternatively used for matching each 
single Obj.1 region with the non-Obj.1 regions sharing the most similar pre-
intervention (1991-1994) characteristics.  Such matching procedure is implemented 
with a radius of tolerance () that represents the maximum distance (in absolute 
value) between the PS of the Obj,1 regions (T=1) and those of the non-Obj.1 
regions (T=0) that are matched together. The radius () that were used in the 
analysis were alternatively:  0.005; 0.01; 0.05; 0.10; 0.154.  
c) Once each Obj.1 region is matched with the group of non-Obj1 regions that shares 
similar pre-intervention characteristics in terms of either Xgrw, X6var or both Xgrw  and 
Xlev, the impact estimates in terms of Average Treatment Effects on the Treated 
(ATT) parameters   are retrieved as:  
  = E [Y1 | T=1, PS]- E [Y0| T=0, PS]    (4) 
5.2 Nearest Available Caliper Matching 
 
The Nearest Available Caliper Matching estimators were implemented in the analysis with 
different values of the caliper () and the same three different sets of control variables used for 
the Radius Matching estimation: (Xgrw), (X6var) and  (Xgrw,  Xlev).   Formally the estimation 
procedure entailed the following steps:  
a) Estimation of the three different probit specifications (1), (2), (3). 
b) The predicted probabilities T^= (X^) from the three probit specifications (1-3) 
represents three sets of Propensity Scores (PS) alternatively used for matching each 
single Obj.1 region with the single non-Obj.1 region that shares the most similar 
pre-intervention (1991-1994) characteristics.  Such matching procedure is 
implemented with a caliper () that represents the maximum distance (in absolute 
value) between the PS of the Obj.1 region (T=1) and the matched non-Obj.1 region 
(T=0).  Obj.1 regions that have a closest non-Obj.1 region with a PS outside the 
caliper of tolerance () are discharged from the analysis. Similarly as for the radius 
matching, the caliper() that were used in the analysis were alternatively:  0.005; 
0.01; 0.05; 0.10; 0.155.  
c) Once each Obj.1 region is matched with the non-Obj1 region that shares the most 
similar pre-intervention characteristics in terms of either Xgrw, X6var or both Xgrw  and 
                                                          
4 The results presented in this report will be drown from the specifications of the radius () that ensure 
the best overall balancing of the pre-intervention control variables, while the complete sets of results will 
be presented in the Appendix. 
5 The results presented in this report will be drown from the specifications of the caliper () that ensure 
the best overall balancing of the pre-intervention control variables, while the complete sets of results will 
be presented in the Appendix. 




Xlev, the impact estimates in terms of Average Treatment Effects on the Treated 
(ATT) parameters   are retrieved as in (4). 
5.3 Kernel Matching 
 
The Kernel Matching estimators were implemented in the analysis with the following different 
smoothing functions: 
• Gaussian, with different bandwidth (the STATA default 0.06, 0.1 and 0.156); 
• Biweight; 
• Epanechnikov. 
The set of control variables used for the estimation are the same (Xgrw), (X6var) and  (Xgrw,  Xlev) 
used for radius and nearest neighborhood matching. More in detail, the estimation procedure 
entailed the following steps: 
a) Estimation of the three different probit specifications (1), (2), (3). 
b) The predicted probabilities T^= (X^) from the three probit specifications (1-3) 
represents three sets of Propensity Scores (PS) alternatively used for the Kernel 
matching procedures based on the different smoothing functions. 
c) The outcome (Y1) of each Obj.1 region is compared with a weighted average of the 
outcomes (Y0) of each non-Obj.1 region with the weights of such average being 
inversely proportional to the distance between the PSs. One of the three different 
smoothing functions alternatively used in the analysis sets the pace of the decline in 
the importance of each non-Obj.1 area in contributing to the comparison average 
(Y0) as the PS of the non-Obj.1 area gets more distant from that of the Obj.1 area. 
5.4 PS estimation and common support 
 
The goal of the Propensity Score Matching (PSM) procedures used in the analysis is to produce 
impact estimates based on comparisons between Obj.1 regions and regions with similar 1991-
1994 growth potentials that were not designated as Obj.1 areas. No matter which PSM 
procedure is used, the potential for obtaining good internal and external validity for the 
analysis crucially relies on the whether or not and actual adequate balancing of the pre-
intervention control variables exists between the treatment (Obj.1 regions) and the comparison 
group (non-Obj1 regions). The existence of such balancing is ensured in the presence of 
adequate “common support” in the estimated Propensity Scores (PS, which can be though as a 
variable which summarizes the relevant pre-intervention confounding factors).  In the following 
Figures 11-13 we depict the boxplots of the PS distributions for the treatment and the 
comparison group. An adequate balancing of the 1991-1994 control variables would produce a 
large overlapping between the PS distributions of the Obj.1 and non-Obj.1 regions (i.e. an 
extensive “common support” is detected).  
                                                          
6 The results in this report will be based on the bandwidth that ensure the best overall balancing of the 
pre-intervention control variables, while the complete sets of results will be presented in the Appendix. 




Figure 11 : Boxplots of the PS distributions based on Xgrw (Growth-trends controls) [All Regions] 
 
T=0 (above): comparison group 
T=1 (below): treatment group 
 
  








Figure 12 : Boxplots of the PS distributions based on three Xgrw (Growth-trend controls) and three Xlev 
(Average-level controls). [All Regions] 
 
T=0 (above): comparison group 
T=1 (below): treatment group 
 
Figure 13 : Boxplots of the PS distributions based on all Xgrw (Growth-trend controls) and Xlev (Average-
level controls). [All Regions] 
 
T=0 (above): comparison group 
T=1 (below): treatment group 
 












As shown in Figures 11-13, the “common support” of the PS distributions for the treated and 
the comparison group is much larger when the analysis is implemented based on the growth-
trend control variables. This is not surprising as the forcing variable Z which determined the 
treatment assignment captured the average per-capita GDP in the years 1988-1990. For this 
reason, the distribution of the average pre-intervention levels of the control variables is much 
different between the treatment and the comparison group than the distribution of the pre-
intervention growth-trends.  
As a consequence PSM estimators that will include also control variables in terms of average 
pre-intervention levels will likely suffer from low common support, and weak statistical 
efficiency (low significance) and external validity. This is due to the small sample of regions for 
which the full set of growth-rates and average-levels control variables are balanced between 
the treatment and the comparison group.  
When the average-level of the control variables are used in the analysis, the unbalance 
between the treatment and the comparison group is not much mitigated even by restricting the 
focus solely on the regions close to the cut-off of the forcing variable Z (Figures 14-16).  Thus, 
applying such restricted focus on the regions in the neighbourhood of the cut-off  would yield 
the same (if not greater) weak statistical efficiency and external validity as in the case of PSM 
estimators implemented on the common support. 
Figure 14 : Boxplots of the PS distributions based on Xgrw (Growth-trends controls). [Regions close to the 
cut-off of eligibility:  Z within  1/4 SD away from the cut-off] 
 
T=0 (above): comparison group 
T=1 (below): treatment group 
 
  








Figure 15 : Boxplots of the PS distributions based on three Xgrw (Growth-trend controls) and three Xlev 
(Average-level controls). [Regions close to the cut-off of eligibility: Z within 1/4 SD away from the cut-off] 
 
T=0 (above): comparison group 
T=1 (below): treatment group 
 





The set of boxplot figures reported above indicates the presence of a trade-off for the analysis: 
controlling for pre-intervention trends ensures higher efficiency, external validity and balancing 












of the growth-rate controls. If also average-levels of the region pre-intervention characteristics 
are to be controlled for, the available data do allow impact identification only for a very small 
number of regions on the common support (with low statistical efficiency and external validity). 
  




6. Summary of the results (Task 1) 
The main results from the analysis are reported in Tables 6-8, which contain the impact 
estimates of the PSM specifications that offer the best overall balancing of the pre-intervention 
covariates within each of the three different types of matching procedures used in the analysis: 
radius, nearest available with caliper and kernel. The complete set of results for all the 
estimated specifications are contained in the Technical Appendix. 
Table 6 : Results from the PS Radius Matching estimators (preferred specifications with the best 















   
ATT 0.829*** 0.528 0.368 
 
   
Balance (%bias) 
   
    d_emprate    -5.5 
 
-11.1 
d_compens  -5.4 -20 20.5 
d_grsfixcapt  -12.8 -3.3 14.4 
d_GDP  -10 -37 8.1 



















The results from the PS radius matching estimator reported in Table 6 indicate that the 
additional intensity of the EUF associated with the Obj.1 eligibility7 generated an average of 
+0.82 percentage points (p.p.) in the yearly growth rate of the per-capita GDP during the 
1995-2006 period. Such additional growth-rate gain is estimated compared to the 
counterfactual yearly growth rate that would have occurred in the absence of the additional 
Obj.1 intensity of the EUF. The +0.82 (p.p.) estimated impact is obtained by estimating the 
counterfactual trend through the yearly GDP data from the non-Obj.1 regions that shared 
similar pre-intervention (1991-1994) growth trends (column 1 of Table 6) of the Obj.1 regions 
in terms of: employment rate (emplrate); worker compensation (wrk_compens), per–capita 
                                                          
7
 As mentioned before, such additional intensity corresponds to a per-capita overall value of EU funds 
greater than 1960 Euro. Further details on the distribution of the per-capita EU funds 1995-2006 
expenditures between Obj.1 and non-Obj.1 regions can be found in Pellegrini et al. 2013. 




GDP (GDP), gross fixed capital formation (gross_fxd_cap_form) and labour productivity (in 
terms of GDP per-worker: lab_prod). 
When the set of control variables used in the analysis includes instead both the growth trends 
and the average pre-intervention levels of three control varaibles [Column 2 of Table 6: worker 
compensation (wrk_compens), per–capita GDP (GDP), gross fixed capital formation 
(gross_fxd_cap_form)], the estimated impact (+0.53 p.p.) fails to reach statistical significance. 
As discussed in the previous sections, this is due to the smaller common support between the 
treatment and the comparison group that is encountered when also the average pre-
intervention levels of the control variables are included in the analysis. The same small 
common support issues plagues also the estimates from the PS specification that includes the 
full set of growth-trends and average pre-intervention levels for all the control variables 
considered in the analysis [column 3 of Table 6: employment rate (emplrate); worker 
compensation (wrk_compens), per–capita GDP (GDP), gross fixed capital formation 
(gross_fxd_cap_form) and labour productivity (in terms of GDP per-worker: lab_prod)]. 
The results from the PS nearest available caliper matching (Table 7) and the Kernel matching 
(Table 8) follows a similar pattern to those from the PS radius matching. The specification (1) 
that controls for the pre-intervention growth-rate trends yields statistically significant impact 
estimates with magnitude close to the that of the radius matching: +1.01 p.p. for the nearest 
available matching (Table 7, column 1); + 0.90 p.p. for the Kernel matching (Gaussian 
smoothing function). For both the nearest available and the kernel matching estimators, 
similarly to the radius matching, the specifications that controls also for the pre-intervention 
average levels (in addition to the pre-intervention growth trends) yield impact estimates with 
no statistical significance: +0.40  and +0,41 p.p. for the nearest available matching estimator 
(Table 7, columns 2 and 3, respectively); +0.53 and +0.34 p.p. for the Gaussian Kernel 
matching estimator (Table 8, columns 2 and 3 respectively).  




Table 7 : Results from the PS Nearest Available estimators with Caliper (preferred specifications) 
Model 
Nearest           
(0.01)           
Grw ctr 
(1) 
Nearest       
 (0.15)             
6 ctr 
(2) 
Nearest       




   
ATT 1.018*** 0.408 0.416 
 
   
Balance (%bias) 
   
    d_emprate    -2.9 
 
-25.5 
d_compens  -7.6 -26.4 22.7 
d_grsfixcapt  -9.9 -9.4 44 
d_GDP  -5.4 -36.4 25.9 
































(0.06)               
6 ctr 
(2) 
Kernel Gaus         




   
ATT 0.901*** 0.528 0.339 
 
   
Balance (%bias) 
   
    d_emprate    -3.6 
 
-18 
d_compens  -6.2 -18.9 21.9 
d_grsfixcapt  -10.2 -1.1 20.3 
d_GDP  -9.7 -37.7 10.8 

























7. Concluding remarks (Task 1) 
The main goal of Task1 was to draw a comparison between RDD and PSM in estimating the 
impact of EUF on regional growth. This is done both through reviewing and comparing some 
theoretical properties of the two types of estimators and by replicating with PSM the 
dichotomous-treatment RDD analysis implemented in the literature (Pellegrini et al. 2013). The 
main findings of this study can be summarized as follows:  
• RDD and PSM are both viable ways to implement regional-level CIEs of the  EUF, however, 
because no true self-selection into applying occurred: RDD does not have the advantage of 
better controlling for unobservable regional characteristics; 
• In order to decide which approach to use:  it’s crucial to assess how dominant is the 
forcing variable as a confounding factor that captures all major risk-factors for selection 
bias and how large is sample of regions near the cut-off point of the forcing variable. If the 
forcing variable is non-dominant and the sample size is small, RDD may fail to ensure 
proper balancing of the relevant control variables (in the same way as randomized 
experiments may fail to ensure proper balancing of all relevant confounding factors with 
small samples). In such circumstance, statistical matching between regions above and 
below the cut-off point of the forcing variable can be seen as conceptually similar to a 
block randomization design (with regard to the relevant control variables) to ensure proper 
balancing in the presence of small samples of regions;  
• If little common support is found for certain controls: both the external validity and the 
statistical efficiency of the estimates will suffer. The ultimate decisions on the types and 
number of control variables to be used in the analysis should be based on specific 
knowledge about factors that have been linked to future regional growth; 
• The results from the present PSM analyses show that the EUF, in the 1995-2006 period, 
spurred additional growth in the amount of 0.8-1 p.p. These results are estimated under 
the assumption that important confounding factors to be controlled for are the pre-
intervention growth-rate trends of the control variables; 
• If instead also the pre-intervention average levels of the control variables are included in 
the Propensity Score estimation, the impact of the EUF on the regional GDP growth is 
somehow lower (0.3-0.5 pp) and the impact estimates fail to reach statistical significance 
because of a very small common support between the treatment and the comparison 
group.  
  






8.  Data (Tasks 2-3) 
The sources of the data used in the analysis are as follows: 
 
8.1 Outcome variables (Y) 
The EU27 GDP data used in the analysis8 were obtained by DG-Regio for the 2000-2011 period 
and from Cambridge Econometrics for the years 1989-1999. The EU27 1989-2011 employment 
rate and gross fixed capital formation data used in the analysis were drown from Cambridge 
Econometrics. At the time of the analysis, no NUTS2-level reliable data were available for the 
years past 2011. For this reason, in agreement with DG-Regio, the observation period covered 
by the analysis spans from 1994 to 2011, for the outcome variables, and from 1994 to 2010 
for the EU Fund (EUF) payments. 
8.2 EU Funds (EUF) per-capita intensities 
In agreement with DG-Regio, the different per-capita intensity of the EUF over the 
programming periods 1994-20139 has been operationalized based on the EU fund payment 
data provided by DG-Regio with details for each operational programme and each year of 
payment from 1976 to 2015. Such EU fund payment information data has been apportioned 
into NUTS2 regions using the percentage of EU fund allocation found in the EPSON database 
(for the 1994-1999 period) and in the EU fund database produced by WIIW and Ismeri 
Europa10.  
The EUF included in the data are: CF (Cohesion Fund), EAGGF (Agricultural Fund), ENPI 
(European Neighbourhood and Partnership Instrument), ERDF (European Regional 
Development Fund), ESF (European Social Fund), FIFG (, IPA (Instrument of Pre-Accession 
Assistance), ISPA (Instrument for Structural Policies for Pre-Accession)11. 
  
                                                          
8 In agreement with DG-Regio, to ensure a better internal consistence of the temporal series of data 
across the different sources, the GDP figures used in the analysis are in terms of GVA. 
9 The period 2007-2013 has been considered up to the year 2010 because of the above-mentioned data 
availability limitation. 
10 Geography of Expenditure, Ex post evaluation of Cohesion Policy programmes 2007-2013, focusing on 
the European Regional Development Fund (ERDF) and the Cohesion Fund (CF). Contract: 
2014CE16BAT067. WIIW and Ismeri Europa, Final Report July 2015. 
11 For Bulgaria and Romania, 2000-06 pre-accession funds cannot be apportioned at the NUTS 2 level. For 
this reason BG and RO NUTS2 are excluded from the analysis in the 2000-06 period. 




8.3 Control variables (X) 
 
For Tasks 2 and 3, the control variables used in the analysis to ensure good balancing between 
the NUTS2 regions pertaining to different groups of EU fund per-capita intensities were 
operationalized as follows: 
 
1994-99 period 
-average annual % growth of per-capita GVA (years 1992-94) 
-average annual change of employment rate (years 1992-94) 
-average annual % change of per-capita gross fixed capital formation (years 1992-94) 
-percentage of employment in agriculture (year 1994) 
-percentage of employment in manufacturing, energy and construction (year 1994) 
-percentage of population 25-64 with high education (year 1994)12. 
2000-06 period 
-average annual % growth of per-capita GVA (years 1997-00) 
-average annual change of employment rate (years 1997-00) 
-average annual % change of per-capita gross fixed capital formation (years 1997-00) 
-percentage of employment in agriculture (year 2000) 
-percentage of employment in manufacturing, energy and construction (year 2000) 
-percentage of population 25-64 with high education (year 2000). 
2007-13 period13 
-average annual % growth of per-capita GVA (years 2004-07) 
-average annual change of employment rate (years 2004-07) 
-average annual % change of per-capita gross fixed capital formation (years 2004-07) 
-percentage of employment in agriculture (year 2007) 
-percentage of employment in manufacturing, energy and construction (year 2007) 
-percentage of population 25-64 with high education (year 2007). 
                                                          
12 Data for the year 1994 is estimated based on extrapolation of the 2000-2011 trend from the Eurostat. 
13 Because the outcome variables data for the analysis are available only up to the year 2011, the EU 
fund payments from the 2007-13 period can be used in the analysis only for the actual 2007-2010 period. 




Aggregate impact estimates for the whole 1994-10 period 
-average annual % growth of per-capita GVA (years 1992-94) 
-average annual change of employment rate (years 1992-94) 
-average annual % change of per-capita gross fixed capital formation (years 1992-94) 
-percentage of employment in agriculture (average level for the year s1992-94) 
-percentage of employment in manufacturing, energy and construction  (average level 
for the years 1992-94) 
-percentage of population 25-64 with high education  (average level for the year 
s1992-94) 
In the sensitivity analysis some alternative specifications of the models also included as control 
variables the average levels of GVA, GFCF and employment rate, recorded in the three years 
before the beginning of the programming period (and in the years 1992-94 in the analyses 
pertaining the whole undivided  1994-2010 period. 
  




9. Caveats and limitations of the data (Tasks 2-3) 
The data available to the analysis pose the following limitations: 
• The EU Fund payments information for the three programming periods were provided by a 
coherent and reliable DG-Regio internal database that contains, sorted by year and county, 
a record for each payment occurred from 1975 to 2015. The NUTS 2 allocation of these 
Funds, within each member state, had to be estimated based on the percentage allocation 
of the Funds computed for different sources of the data.  For the ESF and the EAGGF, the 
NUTS 2 apportioning for the periods 2000-06 and 2007-13 was performed based on the 
share of the total population and the share of agricultural employment.  
• The year in which the EU Fund payments are recoded in the DG-Regio database is an 
administrative record and often it does not indicate the period in which the corresponding 
investment projected was actually completed. In order to account for such potentially 
relevant temporal mismatches, in agreement with DG-Regio we used the following rule to 
apportion the payments to the different periods: 
o the payments of the 1994-99 period were allocated to the same period if they 
had a date from 1994 to 2000 while they were allocated to the 2000-06 period if 
they had a date from 2001 to 2006; 
o the payments of the 2000-06 period were allocated to the same period if they 
had a date from 2000 to 2006 while they were allocated to the 2007-10 period if 
they had a date from 2007 to 2010; 
o the payments of the 2007-10 period were allocated to the same period if they 
had a date from 2007 to 2010. 
• In order to test the sensitivity of the results to such operationalization rules (which entail a 
certain degree of model dependence in the results), we replicated our estimates with a 
model in which the whole 1994-2010 period was considered for the analysis , without 
breaking down the estimates by the single programing periods. 
 
• The payment information on the EUF does not include the specific information on the 
different types of programme interventions and/or investment projects implemented by 
each member-state over the three programming periods examined here. In other words, 
for example, it is not possible to identify how much funding in each region went, for 
example, to business support as opposed to environmental or social infrastructure. The 
exact timing of the specific project implementations is also unknown. In addition, no 
comprehensive information were available on the intensities of the public aids from 
national and regional sources that may affect the NUTS-2 growth outcomes, together with 
the EUF. 
 
All of the above limitations do not enable our empirical evidence to further investigate other 
important conditions under which the different intensities of the EUF produce desirable regional 
growth outcomes. These conditions are, for example, the different compositions and scopes of 
the actual programme interventions, the duration of the project implementations (which may 
affect the temporal lag needed to observe the regional growth outcomes), and the intensities 
of the national or regional sources of public aids that may affect the regional growth outcomes 
in conjunction with the EUF. 
In order to remove such limitation, a much-improved data availability scenario is needed. In 
this regard, it can be recommended to make steps toward the possibility of linking the 
currently available database on the EUF payments with the detailed information on the single 
programmes submitted by the member-states (in terms of: scope and nature of the project; 




exact geographic location, amounts of national/regional co-funding).  Additional information, 
beyond the year 2011, is also needed for a more robust empirical analysis of the last 
programming period (2007-2013), where the heterogeneity across regions is higher, due to 
the presence of new Member States and the largest economic crisis in Europe since WWII was 
in action.  
The empirical findings for this programming period will have to be confirmed when the 
complete data become available. 
 
  




10. Sample sizes and descriptive statistics  (Tasks 2-3) 
10.1 Descriptive statistics on the value of the EU Funds  (EUF) across the 
three programming periods 1994-99; 2000-06;  2007-13 (EU27) 
 
The total value and per-capita value of the aggregate of the EU Funds (EUF) considered in the 
analysis, apportioned by country and by programming period, are illustrated in Table 9 and 10 
, respectively. 
Table 9 : Total EU Funds (1=1 Million €) by country and by period 
Country F_tot94_99 F_tot00_06 F_tot07_13** 
AT 712 1484 2748 
BE 1077 1432 1386 
BG* - - 1912 
CY - 29 268 
CZ - 1030 7969 
DE 16919 24546 17193 
DK 218 515 520 
EE - 355 1787 
ES 36506 47746 21996 
FI 899 1623 1884 
FR 6576 9784 9748 
GR 15698 15424 16126 
HU - 1500 8008 
IE 6958 3904 1983 
IT 15138 22750 16079 
LT - 600 3918 
LU 18 64 82 
LV - 481 2201 
MT - 28 220 
NL 834 1680 1575 
PL - 4563 27486 
PT 17494 18452 11677 
RO* - - 4960 
SE 510 1811 1605 
SI - 211 1622 
SK - 711 4091 
UK 7197 12548 8816 
* The 2000-06 pre-accession funds to Bulgaria  and Romania are excluded from the analysis because of 
lack of reliable and consistent information on the NUTS 2 level apportioning. 
** Data for the 2007-13 period are capped at the year 2010. 
  












AT 90 185 331 
BE 106 140 130 
BG - - 250 
CY - 41 349 
CZ - 100 772 
DE 208 299 209 
DK 42 96 95 
EE - 258 1331 
ES 929 1186 490 
FI 177 313 356 
FR 114 166 157 
GR 1488 1413 1445 
HU - 147 796 
IE 1949 1026 451 
IT 266 400 271 
LT - 171 1213 
LU 45 147 171 
LV - 203 1000 
MT - 72 540 
NL 54 105 96 
PL - 119 721 
PT 1750 1804 1101 
RO - - 238 
SE 58 204 175 
SI - 106 803 
SK - 132 758 
UK 124 213 145 
* Data for the 2007-13 period are capped at the year 2010. 
 
 
In order to better compare the intensities of the EUF across the different periods, Table 11 

















AT 15 26 83 
BE 18 20 33 
BG - - 62 
CY - 6 87 
CZ - 14 193 
DE 35 43 52 
DK 7 14 24 
EE - 37 333 
ES 155 169 123 
FI 29 45 89 
FR 19 24 39 
GR 248 202 361 
HU - 21 199 
IE 325 147 113 
IT 44 57 68 
LT - 24 303 
LU 7 21 43 
LV - 29 250 
MT - 10 135 
NL 9 15 24 
PL - 17 180 
PT 292 258 275 
RO - - 59 
SE 10 29 44 
SI - 15 201 
SK - 19 190 
UK 21 30 36 
** Data for the 2007-13 period are capped at the year 2010. 
 
 
Table 12 contains the information on the pooled distribution of the average annual per-capita 
value of the total EU funds received by each NUTS2 region in the three different programming 
periods. 
The total number of NUTS available to the analysis varies across the three programming 
periods, as a consequence of the annexation of the new EU member states : 204 NUTS2 for 
the 1994-99 period; 245 NUTS2 for the 2000-06 period and 259 NUTS2 for the 2007-13 
period. The pooled total number of NUTS2 used in the analysis is 708.  




Table 12 : Pooled distribution of the NUTS2 annual per-capita EU Fund intensities  in the three 
programming periods  (1=1€ / per capita / per year) 
Total n. NUTS2                  708 
    n. NUTS2 in 1994-99           204 
    n. NUTS2 in 2000-06           245 
    n. NUTS2 in 2007-13           259 
 
Mean                    85.21€ 
Std. Dev.              112.72€  
 
Smallest                0.89€ 
1%                      3.05€ 
5%                      6.47€        
10%                    11.88€        
25%                    19.99€        
Median                 35.19€ 
75%                   112.50€        
90%                   226.13€        
95%                   302.02€        
99%                   541.79€        
Largest               824.88€ 
 
The 25%, 50%, and the75% thresholds of the distribution of Table 12 are used as cut-off 
points to identify 4 categories of the per-capital intensity of the EUF:  
• I Quartile (low intensity) = Avg. annual per-capita EUF in the period below 19.99€  
• II Quartile (medium-low intensity) = Avg. annual per-capita EUF in the period between 
19.99€  and 35.19€ 
• III Quartile (medium-high intensity) = Avg. annual per-capita EUF in the period between 
35.19€ and 112.50€ 
• IV Quartile (high intensity) = Avg. annual per-capita EUF in the period above 112.50€ 
These 4 categories are used in the Propensity Score Matching analysis for estimating the 
impact of multiple categorical treatment intensities. Because of sample size limitations, impact 
estimates based on larger number of discrete intensities of the EUF are not sustainable and 
cannot be used in the analysis. 
Table 13, finally, describes the total sum of the EUF received in the whole period 1994-2010 by 
each of the 259 NUTS2 regions within the EU27 countries. For the EU15 countries these figures 
summarize the EUF payments available in all 1994-2010 years.  For the late member state 
countries, instead, the figures of Table 10 highlight the EUF payment received in the years in 








Table 13 : Total sum of EU Funds received by NUTS2 regions over the whole 1994-2010 period 
country 
F_tot94_10     





AT 4945 623 9 
BE 3895 385 11 
BG 1912 226 6 
CY 296 464 1 
CZ 8999 871 8 
DE 58658 720 38 
DK 1253 241 1 
EE 2142 1450 1 
ES 106248 2704 18 
FI 4406 866 5 
FR 26108 453 22 
GR 47248 4477 13 
HU 9509 919 7 
IE 12846 3597 2 
IT 53968 949 20 
LT 4518 1235 1 
LU 165 408 1 
LV 2682 1064 1 
MT 248 660 1 
NL 4088 266 12 
PL 32049 838 16 
PT 47623 4763 7 
RO 4960 218 8 
SE 3926 447 8 
SI 1833 921 1 
SK 4802 898 4 
UK 28561 494 37 
 
10.2 EU Funds (EUF) in the EU-27 regions sorted by Objective1/Convergence 
Obj. status (years 1994-2010) 
 
Table 14 reports the average annual per-capita intensity of the EU Funds sorted by 
programming period and by Obj.1/Convergence Obj versus Non-Obj1/Non-Convergence Obj 
areas. 
  




Table 14 : Average intensity of the EU Funds (EUF) by Obj.1/Convergence Obj status 
 
 
Table 15 reports the number of NUTS2 regions(sorted by Obj.1/Convergence Obj. status)  
included in each of the four categories of the annual per-capita intensities of the EUF defined 
by the quartiles of the aggregate distribution of Table 12.   
Table 15 : NUTS2 regions sorted by categories of intensities of the EU Funds (EUF) 
 
 
10.3 Descriptive statistics on the outcome variables of the analysis: GVA, 
gross-fixed capital formation and employment rate 
 
Tables 16-18 summarizes the descriptive statistics for the three outcomes of the analysis: 
average annual growth of per-capita GVA; average annual growth of per-capita gross fixed 
capital formation (GFCF) and average annual change of employment rate.  
Such descriptive statistics are sorted by programming period (1994-99 in Table 16; 2000-06 in 
Table 17 and 2007-13 in  Table 18) and by categories of EUF intensities (defined in terms of 
total average annual per-capita value of all EUF received by the NUTS2 regions over the 
programming period).   The four categories of EUF intensities are those defined by the 25%, 
50%, and the75% thresholds of the aggregate distribution over the three periods combined 
(cat. I below 19.99€ annual per-capita EUF; cat. II between 19.99€  and 35.19€; cat. III 
between 35.19€ and 112.50€; cat. IV above 112.50€).  
EU Funds 1994-99*           
(1= 1€  annual  per-capita)
EU Funds 2000-06**           
(1= 1€  annual  per-
capita)
EU Funds 2007-13***         
(1= 1€  annual  per-
capita)
Non- Obj1/Non-conv. Obj. 19 33 50
Obj1/conv. Obj 181 168 178
* EU15 considerd 
**EU15 considered
*** EU27 considered. Funds accounted for In the analysis up to the year 2010
I category         
(1st quartile               
20€<=annual per-
capita)
II category         
(2nd quartile          
20<annual per-
capita<=35€)
III category         
(3rd quartile           
35<annual per-
capita<=112€)
IV category         




N. of Non-Obj1 100 32 16 2
N. of Obj1 0 0 8 46
2000-06 (EU15)
N. of Non-conv. Obj. 39 75 35 6
N. of Conv. Obj 0 0 12 37
2007-13 (EU 27)
N. of Non-conv. Obj. 9 59 90 22
N. of Conv. Obj 0 0 15 64
EU Fund Intensity




Due to data availability limitations, as previously mentioned, the figures for the 2007-13 period 
include EUF up to the year 2010 and GVA, GFCF and employment rate outcomes up to the year  
2011.  
The GVA, GFCF and employment rate outcomes are attributed to each programming period 
with following temporal gaps: 
• the years 1996-2001 are considered for the 1994-99 period; 
• the years 2002-2008 are considered for the 2000-06 period; 
• the years 2009-2011 are considered for the 2007-13 period. 
Such temporal gaps are established for two reasons:  I) to allow enough time after the formal 
conclusion of the programming period for a full completion of all subsidized projects:  II) to 
allow enough time for the possible impacts to occur after the conclusion of the interventions.   
In order to test how sensible the results are to changes of such temporal gap options, we also 
estimate a model in which the whole 1994-2010 period is considered both in terms of the EUF 
allocations and GVA, GFCF and employment rate outcomes. 
Table 16 : Annual average changes of GVA, gross fixed capital formation and employment rate by 








































I 100 10 9 2.38% 2.96% 0.46 
II 32 25 25 2.19% 3.10% 0.26 
III 24 67 66 2.74% 6.62% 0.69 
IV 48 254 220 2.72% 5.35% 0.53 
  




Table 17 : Annual average changes of GVA, gross fixed capital formation and employment rate by 









































I 68 15 15 3.05% 4.44% 0.21 
II 86 27 27 1.81% 1.71% 0.21 
III 48 63 49 1.90% 1.62% 0.29 
IV 43 223 218 1.79% 2.84% 0.34 
 
 
Table 18 : Annual average changes of GVA, Gross fixed capital formation and Employment rate by 




























(1= 1 %) 
Gross Fixed 
Capital 









I 9 18 19 -0.42% -1.84% -0.32 
II 59 28 28 -0.33% -1.99% -0.20 
III 105 60 52 -0.36% -4.28% -0.37 
IV 86 240 191 -0.82% -5.57% -0.71 
 (*)  GVA, Gross fixed capital formation (GFCF) and employment rate outcomes are available consistently 
(for all NUTS2 regions) only until the year 2011. For this reason, the programming period 2007-13 is 
considered only up the year 2010 for the EU Fund payments and up to the year 2011 for the GVA, 
GFCF and employment rate variables. 
 
In the following Figures 17-19, separately for each programming period and for each outcome 
variable, we plot the average annual amount of per-capita EUF received by each NUTS2 region 
against the average yearly change of the outcome variables GVA, GFCF and Employment rate.   




Figure 17: Avg. annual amount of per-capita EUF plotted against the avg. annual growth rate of per-capita 
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Figure 18 : Avg. annual amount of per-capita EUF plotted against the avg. annual growth rate of per-
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Figure 19 : Avg. annual amount of per-capita EUF plotted against the avg. annual growth rate of per-
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Table 19, finally, describes the average annual regional growth of per-capita GVA and GFCF 
and the average annual change of employment rate sorted by Obj.1/Conv. Obj status. 
Table 19 : Average annual growth by Obj.1/Conv. Obj status 
 
1 Avg. annual growth rate (1=1%) 
2 Avg. annual change (1=1 percentage point) 
3 Growth outcomes are measured with two-year gaps: 1996-01 for the first period, 2002-2008 for the 











Non- Obj1/Non-conv. Obj. 150 2.40% 3.46% 0.47 p.p.
Obj1/conv. Obj 54 2.66% 5.39% 0.46 p.p.
2000-06 (EU15)
3
Non- Obj1/Non-conv. Obj. 155 1.56% 1.51% 0.19 p.p.
Obj1/conv. Obj 49 1.83% 2.50% 0.33 p.p.
2007-13 (EU 27)
3
Non- Obj1/Non-conv. Obj. 180 -0.57% -3.28% -0.39 p.p.
Obj1/conv. Obj 79 -0.36% -5.98% -0.55 p.p.




11. Dynamic Propensity Score Matching (PSM) models for estimating the 
average impacts of the highest intensity of the EU Funds (EUF) in the 
Objective 1/Convergence Obj. regions 
For the EU-27 regions and the 1994-2013 periods, the estimates of the average impacts of the 
additional EU Funds (EUF) allocated to the Objective 1/ Convergence Obj. regions have been 
obtained from dynamic specifications of the following Propensity Score Matching (PSM) models: 
• Radius Matching; 
• Nearest Available Caliper Matching; 
• Kernel Matching. 
These dynamic model specifications entails producing local Average Treatment on the treated 
(ATTs) estimates based on each period programming period. Global impact estimates are then 
obtained as  weighted average of the local ATTs, with weights proportional to the number of 
treated Nut2 regions within the common support in each period.  
Details on the exact composition of the variables used in the model are summarized in Table 
20. 
Table 20 : Variable specifications of the Dynamic PSM model with binary treatment intensity (EU-27 
regions, 1994-2013 periods) 
 
Dynamic PSM with binary treatment intensity (run separately in the three periods) 
Outcome data: 
 Avg. annual % growth of GVA; GFCF; avg. annual change of Employment rate 
 I period:  EU15 data (204 NUTS2) outcomes measured in (1996-2001) 
 II period:  EU25 data (245 NUTS2) outcomes measured  in (2002-2008) 
 III period:  EU27 data (259 NUTS2) outcomes measured in (2009-2011) 
Treatment intensity: 
 Binary status:  average highest EUF intensity allocated in the Obj.1/Conv. Obj. regions 
vs. lowest EUF intensity of non-Obj.1/non-Conv. Obj. regions 
Control variables: 
 average annual growth (measured in the following  years before the beginning of each 
period:  I period 1992-94; II period 1997-00, III period 2004-07) of: GVA, GFCF, 
Employment rate 
 percentage of employment (recorded at the beginning of each period:  I period 1994 II 
period 2000; III period 2007) in: agriculture; manufacturing, energy and construction; 
other sectors 
 percentage of population 25-64 with high education (recorded at the beginning of each 
period:  I period 1994 II period 2000; III period 2007) 
Local ATTs are estimated separately for each period. Global impact estimates obtained 
as  weighted average of the local ATTs with weights proportional to the number of treated 
Nut2 regions within the common support in each period. 
Total number of Units of observation:  204 for I period; 245 for II period; 259 for III 
period 
 




12. Generalised Propensity Score (GPS) and Propensity Score Matching 
(PSM) models for estimating the impact of continuous and multiple 
categorical treatment intensities  
The choice of the statistical matching models to estimate the impacts of the continuous and 
multiple categorical treatment intensities stems from considering the causality chain, from EU 
funds (EUF) to desirable regional growth outcomes, illustrated in Figure 20. 
Figure 20 : Causality chain, from EU funds to desirable regional growth outcomes 
 
In order to achieve positive boosting effects on regional growth, the EUF have to be able to 
induce the implementation of additional programmes by the Regional Authorities, compared to 
the counterfactual status of no-EUF.  Such additional programmes may be able to induce 
positive multiplier effects to further boost regional growth.  
 
Thus, a certain degree of temporal lag may exist before the possible multiplier effects and spill-
over effect of the EUF take place. For this reason, the regional growth of the first years of a 
certain programming period may be affected by the EUF of the previous period.. If the regional 
growth outcomes of a given programming period are wrongly assumed to be affected only by 
the EUF intensity of the same period, measurement error consequences would not be 
negligible. For example, in all cases of diminishing support (e.g. transition from Obj.1 –phasing 
out –no Obj.1 /Converge obj.) this could lead to overestimating the impact of low EUF intensity 
and underestimating the impact of high EUF intensity. 
These measurement error consequences may be serious and they lead to considering a trade-
off in designing the statistical matching strategy for estimating the impact of the varying per-
capita EUF intensities. Such trade-off involves the degree of model dependence in the 
estimates and the possibility of exploiting temporal variation of EUF to identify the impact 
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Figure 21 : Trade-off between model dependence and impact identification power 
 
 
In light of the trade-off illustrated in Figure 21, two possible options are available for the 
analyses of the Tasks 2 and 3: 
I) Exploit the variation of the EUF intensity between the different programming periods. 
Such choice implies a moderate degree of model dependence but it allows the analysis 
to exploit the temporal variations of the EUF across the different programming periods.  
II) Exploit only the cross-sectional variation of the EUF intensities by using data aggregated 
over the entire (1994-2010) period of observation for the analysis. Such choice implies 
the lowest degree of model dependence at the expense of a much reduced variation of 
the EUF intensities (with a resulting low impact identification power).  
Based on these two options and on the possibility of operationalizing the variation of the EUF 
intensities in a discrete or continuous way, the following empirical strategies can be used for 
estimating the impacts of the varying EUF intensities (Figure 22). 
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In agreement with DG-Regio, the analyses of Tasks 2 and 3 were implemented using as first 
option the statistical matching models I) and II) of the lower half of Figure 22:  those that do 
exploit the temporal variation (across the three different programming periods) of the EUF 
intensities. This is because the moderate model dependence involved with the need to 
operationalize the temporal lag between the times in which the EUF payments are recorded 
and the times in which the regional growth outcomes are recorded can be effectively handled 
in the following way: 
-the regional growth outcomes, in terms of GVA, employment rate and gross fixed capital 
formation are recorded with a temporal lag of two years following the end of each 
programming period. Thus, for the EUF payments pertaining to the programming period 1994-
99, the regional growth outcomes were measured over the 1996-2001 period.  For the EUF 
payments of 2000-06, the growth outcomes were measured over the 2002-2008 period, while 
for the EUF payments of 2007-13, the growth outcomes were measured over the 2009-2011 
period. 
As sensitivity analysis, however, we implemented also the models III) and IV) of the upper 
part of Figure 22. These models do not exploit the temporal variation (across the three 
different programming periods) of the EU-fund intensities. However they pose the following 
advantages: 
• No assumptions are required to apportion the EUF to the different periods, no model 
dependence is deriving by having to choose a certain temporal lag between the Fund 
payments and the effects produced by the actual underlying investment projects on the 
regional economies of the NUTS 2 regions. 
• For the NUTS 2 regions outside the EU15 Countries, the lack of EUF in the early periods is 
exogenous to their specific economic trends. With the models I) and II) such source of 
exogenous treatment exclusions cannot be exploited because, within each period, only the 
NUTS 2 regions with positive EUF intensities are included.  In the models III) and IV), 
instead, such source of exogenous treatment exclusion can be exploited. This is because 
for each region of the EU27 countries, the models III) and IV) take into consideration the 
aggregate volume of EU funds over the entire undivided 1994-2010 period. In this way, 
the model estimates whether or not the NUTS2 regions with high overall intensities of EUF 
performed better, over the entire 1994-2010 period than the NUTS 2 with low intensities 
but similar initial (pre-1994) local economic and high educational attainments. 
Based on the above-considerations the statistical matching models used for the analyses of 
Tasks 2 and 3 were the following: 
• (Models I) A set of GPS specifications, implemented on pooled longitudinal data obtained 
by operationalizing separately the three periods 1994-99, 2000-06 and 2007-10  
• (Models II) A set of dynamic Propensity Score Matching  (PSM) models with four 
categorical treatment intensities. These PSM models yield local impact estimates (LATT) of 
the four different categories of treatment for each of the three periods. Such LATTs are 
then aggregate to yield the global impact estimates of interest. The different types of PSM 
specifications used in this part of the analysis are: 
o radius matching (with different radius calipers: 0.005; 0.01; 0.05; 0.1). The results 
are shown from the caliper specifications that best preserves the balancing of the 
control variables while maximizing the number of treated regions on common 
support. 
o nearest neighbour with caliper (0.005; 0.01; 0.05; 0.1). Also in this case, the results 
are shown from the caliper specifications that best preserves the balancing of the 




control variables while maximizing the number of treated regions on common 
support. 
o Kernel matching  (Epanechnikov with bandwidth =0.06). 
• (Models III) A set of GPS specifications, implemented on aggregated cross-sectional data 
(EU27) covering the period whole 1994-2010. These models are aimed at estimating the 
impacts of the EUF on the average growth of GDP, GFCF and employment rate changes 
recorded over the entire period 1994-2010. 
• (Models IV) A set of Propensity Score Matching  (PSM) models estimated on the 
aggregated cross-sectional data (EU27) covering the period whole 1994-2010. Similarly to 
the Models II, the different types of PSM specifications used in this part of the analysis are: 
o radius matching (with different radius calipers: 0.005; 0.01; 0.05; 0.1). The results 
are shown from the caliper specifications that best preserves the balancing of the 
control variables while maximizing the number of treated regions on common 
support. 
o nearest neighbour with caliper (0.005; 0.01; 0.05; 0.1). Also in this case, the results 
are shown from the caliper specifications that best preserves the balancing of the 
control variables while maximizing the number of treated regions on common 
support. 
o Kernel matching  (Epanechnikov with bandwidth =0.06). 
Following is a more detailed and formal description of the basic common characteristics of the  
four sets of models (I-IV). 
 
12.1 Generalized propensity score (GPS) matching (Models I, III) 
 
The basic common characteristics of all GPS model used in the analysis can be summarized  
through the following steps:  
 
I) Estimation of the determinants of the treatment intensities 
 
















III) Balance checking: control variables X has be balanced (no statistically-significant 
differences across different treatment intensities) once conditioned to the same 𝐺𝑃?̂? 
 
[X  1 (T=)] | GPŜ 
 
IV) With NUTS 2 –level data (small sample size) the balancing of covariates is checked 
only at very coarsened intervals of the treatment intensities and blocks of GPS  
 
V) Estimation of the conditional expectation of Y given T and GPŜ 
 




E[Y | T, GPS] =f (T, T2, GPŜ, GPŜ2, GPŜ⁡T ) 
 
VI) Estimation of the dose response functions at each  intensity of treatment value T= 
by  averaging the conditional expectation of Y over the GPŜ 
 
12.2 PSM with categorical treatment intensities (Models  II, IV) 
 
All the categorical–treatment PSM specifications used in the analysis  are implemented as a 
modification of the model in Gerfin and Lechner (2000) and Lechner (2002). In our 
specifications the Average Treatment Effects on the Treated (ATTs) (c) are estimated against 
a counterfactual state of receiving the lower intensity category of EUF payments (as supposed 
to a counterfactual state were NUTS2 regions would be randomly assigned to one of the other 
treatment intensities, with probabilities given by weights defined by the relative participation 
frequencies).  
The main common features of our models can be summarized as follows: 
I) Estimation of the predicted probabilities of receiving transfer intensity c=2…n with 
respect to the reference category c=1 
 
P[Tc=2=1] = [h(X)] 
[…] 
P[Tc=n =1] = [h(X)] 
 
II) Elimination of the regions outside the common support 
 
III) Separately for each categorical treatment c, matching of the Tc=1 firms with the 
Tc=1=1 firms with similar propensity score P(X)c. Such matching procedure will be 
implemented replicating the analysis with a number of the different algorithms and 
common support restriction 
IV) Estimation of impacts for each Fund-expenditure intensity category c as differences 
between the mean pre-post intervention outcome changes of the treated (Tc=1) and 
the matched of the benchmark lower intensity category (Tc=1=1). 
12.3 Exact model specifications 
 
Details on the exact composition of the variables used in the four types of models are 
summarized in Tables 21-22. 
  




Table 21 : Variable specifications of Models I -II 
 
Model I: GPS, continuous EUF intensity, longitudinal data on three periods 
Outcome data: 
 Avg. annual % growth of GVA; GFCF; avg. annual change of Employment rate 
 NUTS-2 level (EU 27) pooled longitudinal data on the three periods 
 I period:  EU15 data (204 NUTS2) outcomes measured in (1996-2001) 
 II period:  EU25 data (245 NUTS2) outcomes measured  in (2002-2008) 
 III period:  EU27 data (259 NUTS2) outcomes measured in (2009-2011) 
Treatment intensity: 
 Avg. annual per-capita value of the EUF in each period=  
(Total EU Fund /population in the 1
st
 year of period) / n. years  
Control variables: 
 average annual growth (measured in the following  years before the 
beginning of each period:  I period 1992-9414; II period 1997-00, III 
period 2004-07) of: GVA; GFCF, Employment rate15 
 percentage of employment (recorded at the beginning of each period:  I 
period 1994 II period 2000; III period 2007) in: agriculture; 
manufacturing, energy and construction; other sectors 
 percentage of population 25-64 with high education (recorded at the 
beginning of each period:  I period 1994 II period 2000; III period 2007) 
 Period dummies 
Total number of Units of observation:  708 (i= NUTS2; t= programming periods)  
 
Model II: Dynamic PSM with categorical treatment intensities (run separately in 
the three periods) 
Outcome data: 
 Avg. annual % growth of GVA; GFCF; avg. annual change of Employment rate 
 I period:  EU15 data (204 NUTS2) outcomes measured in (1996-2001) 
 II period:  EU25 data (245 NUTS2) outcomes measured  in (2002-2008) 
 III period:  EU27 data (259 NUTS2) outcomes measured in (2009-2011) 
Treatment intensity: 
 4 categories of the EUF intensities based on quartiles of the overall 
distribution across the three periods 
Control variables: 
 average annual growth (measured in the following  years before the 
beginning of each period:  I period 1992-94; II period 1997-00, III period 
2004-07) of: GVA, GFCF, Employment rate 
 percentage of employment (recorded at the beginning of each period:  I 
period 1994 II period 2000; III period 2007) in: agriculture; 
manufacturing, energy and construction; other sectors 
 percentage of population 25-64 with high education (recorded at the 
beginning of each period:  I period 1994 II period 2000; III period 2007) 
Local ATTs are estimated separately for each period. Global impact estimates 
obtained as  weighted average of the local ATTs with weights proportional to 
the number of treated Nut2 regions within the common support in each period. 
                                                          
14 We consider 1992-94 instead of 1991-94 because the 1991 data was missing for a number of NUTS2 
region. 
15 In terms of average annual change. 




Total number of Units of observation:  204 for I period; 245 for II period; 259 
for III period 
 
 
Table 22 : Variable specifications of Models III-IV 
 
Model III: GPS continuous EUF intensity, whole 1994-2010 period 
 
Outcome data: 
 Avg. annual % growth of GVA; GFCF; avg. annual change of Employment rate 
 NUTS-2 level (EU 27) cross-sectional data  
Treatment intensity: 
 Avg. per-capita value of the EUF in the whole 1994-2010 period=  
(Total EU Fund /1994 population)  
Control variables: 
 average annual growth (measured in 1992-94): GVA; GFCF, Employment rate 
 average percentage of employment (in the years1992-94) in: agriculture; 
manufacturing, energy and construction; other sectors 
 percentage of population 25-64 with high education (recorded in 1994) 
Total number of Units of observation: 259  
 
 
Model IV: PSM with categorical treatment intensities, whole 1994-2010 period 
 
Outcome data: 
 Avg. annual % growth of GVA; GFCF; avg. annual change of Employment rate 
 I period:  EU15 data (204 NUTS2) outcomes measured in (1996-2001) 
 II period:  EU25 data (245 NUTS2) outcomes measured  in (2002-2008) 
 III period:  EU25 data (259 NUTS2) outcomes measured in (2009-2011) 
Treatment intensity: 
 4 categories of EUF intensities based on quartiles of the avg. per-capita 
value of the EUF in the whole 1994-2010 period= (Total EU Fund /1994 
population)  
Control variables: 
 average annual growth (measured in 1992-94): GVA; GFCF, Employment rate 
 average percentage of employment (in the years1992-94) in: agriculture; 
manufacturing, energy and construction; other sectors 
 percentage of population 25-64 with high education (recorded in 1994) 








13. Summary of the results (Tasks 2 and 3) 
 
For the EU27 regions, in the 1994-99, 2000-06 and 2007-1316 periods, the higher average 
annual per-capita intensity of EU Funds (EUF) devoted to the Obj.1 /Convergence Obj. regions 
yielded the impacts summarized in the Tables 23-25. 
Table 23 : Impacts of EU Funds (EUF) on GVA growth. EU-27,  1994-2011 
 
 
Table 23 summarizes the estimated impacts on GVA growth. The higher average annual per-
capita intensity of EUF devoted to the Obj.1 or convergence Obj. regions (compared to the 
counterfactual status of receiving the lower average intensity of the Non-Obj.1/Non-converg. 
Obj. regions) determines an increase in the annual growth of per-capita GVA from  +0.55 
percentage point (p.p.), in the radius matching specification, to +0.72 p.p. , in the kernel 
matching specification. 
The results on gross fixed capital formation (GFCF, in terms of annual per-capita growth) are 
reported in Table 24. The GFCF impacts of the higher EUF intensity of the Obj.1/Convergence 
Obj. regions are similar to the GVA results, ranging from +0.51 p.p. (in the radius matching 
specification) to +1.10 p.p.(in the nearest available matching specification). Due to high 




                                                          
16
 As mentioned earlier in this report, because of data availability limitations, the 2007-13 period is 
capped at the year 2010 for the EU Funds and the year 2011 for the regional growth variables. 
Impact estimates of the Highest EUF intensity 






Radius matching (=0.05) 0.0055*** 0.0025 107
Nearest available matching (caliper = 0.05) 0.0067* 0.0044 107
Kernel matching (Epanechnikov) 0.0072*** 0.0033 115




Table 24 : Impacts of EU Funds (EUF) on Gross fixed capital formation growth. EU-27, 1994-2011 
Impact estimates of the Highest EUF intensity 








Radius matching (=0.05) 0.0051 0.0068 107 
Nearest available matching (caliper = 0.05) 0.0110 0.0177 107 
Kernel matching (Epanechnikov) 0.0098 0.0089 115 
 
Table 25, finally, reports the impacts on the yearly change of employment rate. In this case, 
the impact estimates of the higher EUF intensity of the Obj.1/Convergence Obj. regions are of 
a smaller magnitude: +0.10 p.p. in the radius matching specification, and +0.12 p.p. in the 
nearest available and kernel matching specification. Similarly as in the GFCF results, also in 
this case, the high standard errors of the impact estimates do not enable the impact estimates 
to reach statistical significance. 




Table 25 : Impacts of EU Funds (EUF) on employment rate changes. EU-27, 1994-2011 
 
 
The PSM differential impacts of four different levels of the EUF intensities received by each 
NUTS2 region and the GPS impacts of each additional unit of intensity of the EUF at each 
continuous level across the entire distribution (regardless to the Obj1-Converg. Obj. status of 
the region), do not display a very high degree of robustness and statistical significance across 
the different models and specifications. 
This is due to the fact that splitting the sample of the NUTS2 regions into multiple categories of 
regions based on different intensities of the EUF further reduces the possibility of finding 
suitable groups of regions with similar pre-intervention characteristics but belonging to 
different categories of EUF intensity. In this regard, our analysis shows that at the NUTS 2 
level, the small sample size of EU regions available to the analysis does not guarantee the 
possibility of undertaking a rigorous counterfactual impact evaluation of very detailed different 
levels of EUF intensity. 
Due to the above reasons, it is not possible to summarize in a coherent set of unique findings 
the heterogeneous and often volatile estimates from all the estimated categorical PSM models 
and the dose-response and treatment effect functions from the GPS models. We refer instead 
to the technical appendix of this report for a complete illustration of the categorical PMS and 
GPS results concerning the differential impacts of the varying intensities of the EUF on GVA and 
GFCF growth outcomes and employment changes outcomes. 
  
Impact estimates of the Highest EUF intensity 






Radius matching (=0.05) 0.0010 0.0009 107
Nearest available matching (caliper = 0.05) 0.0012 0.0011 107
Kernel matching (Epanechnikov) 0.0012 0.0013 115




14. Concluding remarks (Tasks 2 and 3) 
The findings from the Task 2 and task 3 analyses show that, within the EU-27 regions and in 
the 1994-2011 period, the EU Funds (EUF) had a significant role in stimulating regional growth 
and economic development. Our impact estimates indicate that the higher average intensity of 
the EUF in the Ob.1/Convergence regions generates a positive effect on various regional 
growth outcomes, compared to the counterfactual status of the lower average EUF intensity of 
the non-Ob.1/non-Convergence regions. These impacts are in line with the results of other 
studies cast in a counterfactual framework. 
The results from estimating the different impacts of the continuous or discrete changes of the 
EUF intensities across the different NUTS2 regions are hard to summarize and cannot offer 
clear-cut interpretations and/or policy recommendations. This is due to multiple data 
limitations, and, ultimately to the reduced sample size of regions that display very similar pre-
intervention characteristics but different levels of EUF intensity. Nevertheless, the results from 
this study, combined with the results from the WP 14c (focusing on Regression Discontinuity 
Design techniques) point in the direction of showing that the marginal impact on regional 
growth of further increasing the intensity of the EUF tends to be higher for the regions that do 
not already receive an high intensity of the EUF. In other world, the marginal impact on growth 
of adding more EUF intensity tends to decrease for the regions with high EUF intensities.  
A great deal of caution, however, should be exerted in interpreting these results as supportive 
of the hypothesis that diminishing returns to investment and/or limited absorption capacities 
may be in place to hamper the full economic-development potential of the high intensities of 
the EUF transfers.  
This is for the following two reasons. First, the EUF transfers may have also other objectives 
apart from regional growth. Portions of the high EUF intensity of certain regions may be 
devoted to fulfil such diverse objectives, leading to a violation of the linearity in the 
relationship between EUF intensity and growth. Second, in regional-level counterfactual impact 
evaluation studies (CIE), like ours, the bulk of the empirical evidence comes from cross-
sectional variation of the EUF intensities across the different regions. Variations of the EUF 
intensity within a same region are instead much more limited, as they are observed only across 
the three past programing periods. 
For this reason the analysis has to face the challenge that the regions with high EUF intensities 
could be the most problematic ones, where the effect on growth would be less than elsewhere 
for any given level of EUF. Our Propensity Score Matching (PSM) and Generalised Propensity 
Score (GPS) analysis, aims at controlling for such potential differences between regions, 
producing impact estimates that indicate the net impact of the varying EUF intensity, holding 
constant every other regional characteristic (i.e. mimicking the results of an experiment in 
which the impacts of the EUF are estimated by mean of comparing the growth outcomes of 
regions with different levels of funding but identical characteristics). In this study, however, 
some regional features are unobservable in the available data (e.g. administrative and geo-
physical characteristics, for PSM). For these reasons we cannot empirically confirm that a full 
balancing is perfectly achieved in our analysis between the regions with different levels of EUF 
intensity with regard to the characteristics that are not included in the data. This circumstance 
warrens further caution in extrapolating strong policy conclusions from the empirical evidence 
obtained within the data currently available. 




Moreover, the strong limitations in the current data-availability scenario on the EUF payments 
do not enable any type of CIE analysis, including ours, to further investigate other important 
conditions under which the different intensities of the EUF produce desirable regional growth 
outcomes. These conditions are, for example, the different compositions and scopes of the 
actual programme interventions, the duration of the project implementations (which may affect 
the temporal lag needed to observe the regional growth outcomes), and the intensities of the 
national or regional sources of public aids that may affect the regional growth outcomes in 
conjunction with the EUF.  
In order to overcome such data limitations it could be advisable to explore the possibility of 
linking the currently available EUF database with the detailed information on the single 
programmes submitted by the member-states for the EUF payments, as explicitly considered in 
Work Package 13 – Geography of Expenditure. 
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Annex 1: Task 1 - Technical Appendix 
 
Complete PSM impact estimates (EU-15, 1994-2006 periods) 
 
 
A.1 Radius Matching estimates (GDP outcome) 
 
The complete radius matching impact estimates of the EU Funds (EUF) on the average 
per-capita GDP growth, for the EU-15 regions, in the 1994-06 period (Task 1) are 
presented in the Tables included in the sections from A.1.1 (models with growth-rate 
control variables) to A.1.3 (model with all control variables9.   
 





. *RADIUS delta=0.005 GRW CTR * 
. psmatch2 T, radius caliper(0.005) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.31906108   1.27388374   1.04517734   .249743937     4.18 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        19         34 |        53  
-----------+----------------------+---------- 
     Total |        19        163 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2105  -1.1406     -5.7    58.8 |  -0.26  0.797 |  1.55 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  |-.28555   1.4386    -32.7     9.6 |  -2.13  0.037 | 11.16* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  |-2.3111  -.59516    -34.8   -57.9 |  -1.72  0.091 |  1.80 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .20743   1.0792    -20.8    -9.1 |  -1.37  0.174 |  6.29* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 1.4789   2.2768    -18.4   -22.7 |  -1.20  0.236 |  5.61* 
                          |                                  |               | 
---------------------------------------------------------------------------------------- 
 







. *RADIUS delta=0.01 GRW CTR* 
. psmatch2 T, radius caliper(0.01) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.36082391   1.53173681   .829087098   .223870247     3.70 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        13         40 |        53  
-----------+----------------------+---------- 
     Total |        13        169 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.1565  -1.0888     -5.5    60.1 |  -0.25  0.803 |  1.03 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  |  1.021   1.3079     -5.4    85.0 |  -0.31  0.754 | 14.97* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  |-1.6421  -1.0094    -12.8    41.8 |  -0.64  0.525 |  1.63 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .65578   1.0758    -10.0    47.4 |  -0.63  0.530 |  6.03* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 1.8779   2.2303     -8.1    45.8 |  -0.49  0.626 |  4.38* 
                          |                                  |               | 
---------------------------------------------------------------------------------------- 
  







. *RADIUS delta=0.05 GRW CTR* 
. psmatch2 T, radius caliper(0.05) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.78565311   .687087479   .222756406     3.08 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.2098     25.2   -82.4 |   0.97  0.337 |  0.54* 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.3586     33.6     6.9 |   1.73  0.086 | 26.30* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042  -1.8951     17.3    21.5 |   0.92  0.358 |  1.78* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134   1.0139     19.1    -0.0 |   0.99  0.327 | 12.58* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872   2.3345     10.4    30.4 |   0.53  0.601 |  7.54* 















. *RADIUS delta=0.01 6CTR* 
. psmatch2 T, radius caliper(0.05) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.61695877   .528016046   1.11161846     0.47 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6827    -20.0    44.6 |  -0.83  0.424 |  3.99 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   1.9463     -3.3    84.9 |  -0.05  0.958 |  0.43 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.7131    -37.0   -94.4 |  -0.94  0.369 |  9.88* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25540     12.2    93.9 |   0.40  0.695 |  1.10 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3744.3    -20.2    63.8 |  -0.24  0.813 |  0.54 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18519    -10.6    95.7 |  -0.27  0.796 |  0.19 










. *RADIUS delta=0.05 6CTR* 
. psmatch2 T, radius caliper(0.05) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.61695877   .528016046   1.11161846     0.47 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6827    -20.0    44.6 |  -0.83  0.424 |  3.99 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   1.9463     -3.3    84.9 |  -0.05  0.958 |  0.43 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.7131    -37.0   -94.4 |  -0.94  0.369 |  9.88* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25540     12.2    93.9 |   0.40  0.695 |  1.10 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3744.3    -20.2    63.8 |  -0.24  0.813 |  0.54 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18519    -10.6    95.7 |  -0.27  0.796 |  0.19 










. *RADIUS delta=0.1 6CTR* 
. psmatch2 T, radius caliper(0.05) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.61695877   .528016046   1.11161846     0.47 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6827    -20.0    44.6 |  -0.83  0.424 |  3.99 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   1.9463     -3.3    84.9 |  -0.05  0.958 |  0.43 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.7131    -37.0   -94.4 |  -0.94  0.369 |  9.88* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25540     12.2    93.9 |   0.40  0.695 |  1.10 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3744.3    -20.2    63.8 |  -0.24  0.813 |  0.54 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18519    -10.6    95.7 |  -0.27  0.796 |  0.19 














*RADIUS delta=0.05 ALL CTR* 
. psmatch2 T, radius caliper(0.05) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 3.30378923   1.68427378   1.61951545   1.00894436     1.61 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        49          4 |        53  
-----------+----------------------+---------- 
     Total |        49        133 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2707  -.47941    -64.5  -366.4 |  -0.58  0.581 |  3.86 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 1.9488   .90869     19.7    45.5 |   0.71  0.504 |  2.14 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.9689   1.8939     21.8     1.1 |   0.32  0.758 |  0.72 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.3553   1.5122     20.1    -5.5 |   0.69  0.518 |  2.71 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.7519   2.0278     39.7  -165.1 |   1.66  0.147 |  0.29 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  24500    25660    -20.1    89.9 |  -0.63  0.552 |  0.19 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3715.5   3347.6     26.4    52.8 |   0.31  0.770 |  3.24 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18614    18330      7.7    96.9 |   0.22  0.832 |  0.56 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  49725    49953     -2.8    98.5 |  -0.05  0.964 |  1.12 










. *RADIUS delta=0.1 ALL CTR* 
. psmatch2 T, radius caliper(0.1) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.07205268   1.70538365   .366669026   1.10814071     0.33 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2033  -.61506    -48.0  -246.8 |  -0.64  0.536 |  2.52 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.4033   1.2046     41.6   -15.2 |   0.85  0.415 | 16.61* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.3857   1.1023     26.0   -18.1 |   0.52  0.613 |  1.08 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.8046    1.511     30.8   -61.9 |   0.51  0.621 | 27.76* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  |  4.099   2.1684     44.5  -196.8 |   0.80  0.440 | 11.11* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  24104    25603    -25.9    86.9 |  -0.82  0.433 |  1.23 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 4204.9   3459.7     53.4     4.4 |   0.71  0.492 |  2.52 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17737    17987     -6.7    97.3 |  -0.21  0.838 |  1.08 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  46481    49771    -40.7    77.7 |  -0.73  0.483 |  2.41 










. *RADIUS delta=0.15 ALL CTR* 
. psmatch2 T, radius caliper(0.15) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.00694341   1.63839134   .368552071   .989817007     0.37 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        46          7 |        53  
-----------+----------------------+---------- 
     Total |        46        136 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.0343  -.89788    -11.1    19.6 |  -0.18  0.863 |  3.27 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 2.6591   1.5764     20.5    43.3 |   0.47  0.647 | 19.72* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.2911   1.5809     14.4    34.6 |   0.34  0.739 |  1.08 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.9828   1.6415      8.1    57.3 |   0.15  0.884 | 28.97* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.0951    2.586     11.7    21.7 |   0.23  0.824 | 20.78* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  25129    25664     -9.2    95.3 |  -0.28  0.787 |  1.72 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3980.5   3209.5     55.2     1.1 |   0.88  0.398 |  3.66 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17577    17958    -10.3    95.9 |  -0.27  0.794 |  0.37 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  46507    49074    -31.7    82.6 |  -0.66  0.521 |  2.14 









A.2 Nearest Available Matching estimates (GDP outcome) 
 
The complete Nearest Available Matching impact estimates for the Task 1 analyses are 
detailed in the following Tables of the sections A.2.1 – A.2.3.  
 
 




. *CALIPER=0.005 * 
. psmatch2 T, caliper(0.005) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.31906108    1.2724314   1.04662968   .270747065     3.87 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        19         34 |        53  
-----------+----------------------+---------- 
     Total |        19        163 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2105  -1.1531     -4.7    66.2 |  -0.21  0.835 |  1.46 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  |-.28555   1.5097    -34.0     5.9 |  -2.21  0.031 |  9.64* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  |-2.3111   -.5218    -36.3   -64.7 |  -1.82  0.073 |  1.97 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .20743    .9712    -18.2     4.4 |  -1.20  0.234 |  6.16* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 1.4789   2.1823    -16.2    -8.2 |  -1.05  0.299 |  5.18* 










. *CALIPER=0.01 * 
. psmatch2 T, caliper(0.01) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.36082391   1.34187195   1.01895196   .241852958     4.21 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        13         40 |        53  
-----------+----------------------+---------- 
     Total |        13        169 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.1565  -1.1206     -2.9    78.8 |  -0.13  0.896 |  1.01 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  |  1.021   1.4213     -7.6    79.0 |  -0.44  0.663 | 13.65* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  |-1.6421  -1.1565     -9.9    55.3 |  -0.50  0.617 |  1.85 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .65578   .88367     -5.4    71.5 |  -0.34  0.733 |  6.12* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 1.8779   2.0687     -4.4    70.7 |  -0.27  0.790 |  4.85* 










. *CALIPER =0.05 * 
. psmatch2 T, caliper(0.05) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.58653568   .886204904   .232963179     3.80 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.3205     34.3  -147.7 |   1.31  0.191 |  0.54* 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.4622     31.7    12.3 |   1.63  0.106 | 23.94* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042  -2.0425     20.3     7.9 |   1.10  0.274 |  1.94* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134   .87765     22.3   -17.1 |   1.16  0.251 | 13.15* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872    2.315     10.9    27.4 |   0.55  0.586 |  7.30* 
















. *CALIPER=0.05 * 
. psmatch2 T, caliper(0.05) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.71596671   .429008107   1.09470163     0.39 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6997    -20.3    43.7 |  -0.80  0.441 |  2.55 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825    2.476    -14.1    36.2 |  -0.24  0.818 |  0.48 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   2.2715    -50.3  -164.3 |  -1.30  0.221 | 17.46* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    24274     34.0    82.8 |   1.49  0.166 | 10.85* 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3628.4    -11.9    78.6 |  -0.17  0.865 |  1.08 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18075      1.3    99.5 |   0.05  0.960 |  0.63 










. *CALIPER=0.1 * 
. psmatch2 T, caliper(0.1) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.71596671   .429008107   1.09470163     0.39 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6997    -20.3    43.7 |  -0.80  0.441 |  2.55 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825    2.476    -14.1    36.2 |  -0.24  0.818 |  0.48 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   2.2715    -50.3  -164.3 |  -1.30  0.221 | 17.46* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    24274     34.0    82.8 |   1.49  0.166 | 10.85* 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3628.4    -11.9    78.6 |  -0.17  0.865 |  1.08 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18075      1.3    99.5 |   0.05  0.960 |  0.63 










. *CALIPER=0.15 * 
. psmatch2 T, caliper(0.15) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.11997134   1.71142497   .408546364   .922880688     0.44 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        46          7 |        53  
-----------+----------------------+---------- 
     Total |        46        136 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .42041   1.8149    -26.4    26.9 |  -1.21  0.250 |  2.58 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.9325   2.3938     -9.4    57.6 |  -0.19  0.856 |  0.48 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .65238   2.1774    -36.4   -90.8 |  -1.05  0.316 | 18.26* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  25279    24451     14.3    92.8 |   0.56  0.587 | 15.19* 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3329.6   3491.7    -11.6    79.2 |  -0.20  0.849 |  1.07 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17923    17761      4.4    98.2 |   0.18  0.858 |  0.59 
















. *CALIPER=0.05 * 
. psmatch2 T, caliper(0.05) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 3.30378923   1.37711556   1.92667366   1.04855641     1.84 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        49          4 |        53  
-----------+----------------------+---------- 
     Total |        49        133 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod , both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2707  -.92758    -28.0  -102.3 |  -0.24  0.816 |  2.82 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 1.9488   1.4791      8.9    75.4 |   0.33  0.751 |  2.68 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.9689  -.38237     68.0  -208.4 |   1.18  0.283 |  1.36 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.3553    .6438     40.8  -114.2 |   1.56  0.171 | 10.24 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.7519   1.6284     48.9  -226.5 |   2.23  0.067 |  0.36 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  24500    25883    -23.9    87.9 |  -0.59  0.575 |  0.11 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3715.5   3621.6      6.7    88.0 |   0.08  0.937 |  6.18 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18614    18050     15.2    93.9 |   0.49  0.644 |  0.78 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  49725    51582    -22.9    87.4 |  -0.45  0.667 |  2.81 











. *CALIPER=0.1 * 
. psmatch2 T, caliper(0.1) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.07205268   1.57463732   .497415353   1.14386699     0.43 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod , both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2033  -.65806    -44.5  -221.4 |  -0.57  0.579 |  2.00 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.4033   1.2886     40.0   -10.8 |   0.82  0.433 | 15.65* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.3857  -.17292     51.9  -135.5 |   1.18  0.265 |  2.00 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.8046    .7761     48.4  -153.8 |   0.81  0.436 | 86.07* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  |  4.099   1.4812     60.3  -302.5 |   1.09  0.300 | 12.02* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  24104    26342    -38.7    80.4 |  -1.10  0.295 |  0.82 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 4204.9   3606.7     42.8    23.3 |   0.63  0.544 |  6.18 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17737    18029     -7.9    96.8 |  -0.25  0.805 |  1.22 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  46481    52187    -70.5    61.3 |  -1.37  0.201 |  4.80 










. *CALIPER=0.15 * 
. psmatch2 T, caliper(0.15) outcome (Y) pscore(PS_allctr) 
 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.00694341    1.5902855   .416657915   .998924867     0.42 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        46          7 |        53  
-----------+----------------------+---------- 
     Total |        46        136 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod , both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.0343  -.72222    -25.5   -84.0 |  -0.38  0.712 |  2.09 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 2.6591   1.4625     22.7    37.3 |   0.52  0.615 | 15.90* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.2911   .12331     44.0   -99.5 |   1.17  0.266 |  1.86 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.9828   .89558     25.9   -36.0 |   0.48  0.641 | 77.64* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.0951   1.6643     33.0  -120.0 |   0.63  0.540 | 13.76* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  25129    26224    -18.9    90.4 |  -0.55  0.594 |  1.46 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3980.5   3473.1     36.3    34.9 |   0.60  0.560 |  5.63 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17577    17722     -3.9    98.4 |  -0.14  0.891 |  1.05 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  46507    51783    -65.2    64.2 |  -1.49  0.163 |  4.46 








A.3 Kernel Matching (GDP outcome) 
 
The complete kernel matching impact estimates for the Task 1 analyses are presented 
in the Tables included in the following sections: 
- from A.3.1 to A.3.3 for the Gaussian Kernel Matching, implemented with different 
bandwidth (0.06, 0.1 and 0.15); 
- from A.3.4 to A.3.6 for the Biweight Kernel Matching; 
- from A.3.7 to A3.9 for the Epanechnikov Kernel Matching. 
 




. *KERNEL GAUSSIAN * 
. psmatch2 T, kernel outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.77116297   .701577614   .224437687     3.13 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.1838     23.1   -67.1 |   0.89  0.378 |  0.54* 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.3378     34.0     5.8 |   1.75  0.082 | 26.38* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042  -1.8875     17.2    22.2 |   0.92  0.361 |  1.82* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134    1.031     18.7     2.1 |   0.96  0.337 | 12.43* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872   2.3239     10.7    28.8 |   0.54  0.592 |  7.50* 










. *KERNEL GAUSSIAN bandwith 0.1 * 
. psmatch2 T, kernel outcome (Y) pscore(PS_grwctr) bw(0.1) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.78162937   .691111221   .222425615     3.11 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.1813     22.9   -65.6 |   0.89  0.377 |  0.56* 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.3427     33.9     6.0 |   1.75  0.083 | 26.26* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042   -1.793     15.2    30.9 |   0.82  0.412 |  1.92* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134   1.0096     19.2    -0.6 |   0.99  0.323 | 13.36* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872   2.2972     11.3    24.7 |   0.57  0.570 |  7.80* 











. *KERNEL GAUSSIAN bandwith 0.15 * 
. psmatch2 T, kernel outcome (Y) pscore(PS_grwctr) bw(0.15) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.73079088   .741949706    .21224972     3.50 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.1745     22.4   -61.6 |   0.88  0.378 |  0.60 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.3558     33.7     6.7 |   1.74  0.085 | 26.24* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042  -1.8138     15.7    29.0 |   0.84  0.402 |  1.85* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134   .99148     19.6    -2.8 |   1.01  0.313 | 12.58* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872   2.2676     12.0    20.1 |   0.60  0.547 |  7.86* 














. *KERNEL GAUSSIAN * 
. psmatch2 T, kernel outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482    1.6165416   .528433221   1.10653988     0.48 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6253    -18.9    47.6 |  -0.79  0.450 |  3.89 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   1.8384     -1.1    94.9 |  -0.02  0.986 |  0.44 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.7422    -37.7   -98.0 |  -0.96  0.361 |  9.83* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25439     13.9    93.0 |   0.46  0.659 |  1.04 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3730.6    -19.3    65.5 |  -0.23  0.822 |  0.54 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18502    -10.2    95.9 |  -0.25  0.806 |  0.19 












. *KERNEL GAUSSIAN bandwith 0.1 * 
. psmatch2 T, kernel outcome (Y) pscore(PS_6ctr) bw(0.1) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.66535012   .479624703   1.08908332     0.44 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.3379    -13.5    62.7 |  -0.57  0.580 |  4.82 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   1.0955     13.9    36.8 |   0.21  0.835 |  0.37 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.9665    -43.1  -126.1 |  -1.08  0.307 |  7.44* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25418     14.3    92.8 |   0.46  0.655 |  0.98 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   4135.8    -48.3    13.5 |  -0.48  0.642 |  0.32 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18507    -10.3    95.9 |  -0.26  0.801 |  0.19 














. *KERNEL GAUSSIAN bandwith 0.15 * 
. psmatch2 T, kernel outcome (Y) pscore(PS_6ctr) bw(0.15) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.11997134   1.68777473   .432196603   .932849957     0.46 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        46          7 |        53  
-----------+----------------------+---------- 
     Total |        46        136 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .42041   1.4493    -19.5    46.1 |  -0.94  0.364 |  4.23 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.9325   1.0955     17.0    23.0 |   0.32  0.757 |  0.41 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .65238   1.9737    -31.5   -65.3 |  -0.88  0.396 |  8.41* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  25279    25341     -1.1    99.5 |  -0.03  0.973 |  1.76 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3329.6   3833.8    -36.1    35.3 |  -0.43  0.677 |  0.34 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17923    18054     -3.5    98.6 |  -0.10  0.922 |  0.20 














. *KERNEL GAUSSIAN * 
. psmatch2 T, kernel outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 3.30378923   1.70897436   1.59481486   1.02101514     1.56 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        49          4 |        53  
-----------+----------------------+---------- 
     Total |        49        133 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2707  -.52817    -60.6  -337.7 |  -0.54  0.609 |  3.37 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 1.9488   .99714     18.0    50.1 |   0.65  0.540 |  2.10 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.9689   1.8753     22.2    -0.6 |   0.32  0.758 |  0.68 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.3553   1.5097     20.2    -5.8 |   0.69  0.517 |  2.71 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.7519   2.0791     38.5  -157.2 |   1.59  0.163 |  0.28 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  24500    25694    -20.6    89.6 |  -0.65  0.540 |  0.19 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3715.5   3336.1     27.2    51.3 |   0.31  0.764 |  3.16 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18614    18299      8.5    96.6 |   0.25  0.812 |  0.57 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  49725    49889     -2.0    98.9 |  -0.03  0.974 |  1.09 













. *KERNEL GAUSSIAN bandwidth 0.15* 
. psmatch2 T, kernel outcome (Y) pscore(PS_allctr) bw(0.15) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.00694341   1.66754307    .33940034   .991638479     0.34 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        46          7 |        53  
-----------+----------------------+---------- 
     Total |        46        136 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.0343   -.8132    -18.0   -30.3 |  -0.28  0.784 |  2.82 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 2.6591   1.5014     21.9    39.3 |   0.50  0.625 | 17.77* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.2911   1.2897     20.3     7.8 |   0.49  0.634 |  1.15 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.9828   1.5279     10.8    43.1 |   0.20  0.846 | 29.65* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.0951   2.3864     16.3    -9.0 |   0.31  0.759 | 16.31* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  25129    25853    -12.5    93.7 |  -0.37  0.716 |  1.69 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3980.5   3295.8     49.0    12.2 |   0.77  0.454 |  3.53 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  17577    18043    -12.6    95.0 |  -0.33  0.747 |  0.38 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  46507    49770    -40.3    77.9 |  -0.84  0.416 |  2.17 



















. *KERNEL BIWIGHT * 
. psmatch2 T, kernel k(biweight) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.76644339   .706297198   .225301143     3.13 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.1889     23.5   -70.1 |   0.90  0.370 |  0.54* 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.3436     33.9     6.1 |   1.75  0.083 | 26.53* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042   -1.893     17.3    21.7 |   0.92  0.358 |  1.80* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134    1.056     18.1     5.2 |   0.93  0.353 | 12.38* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872   2.3548     10.0    33.5 |   0.50  0.617 |  7.46* 

















. *KERNEL BIWIGHT * 
. psmatch2 T, kernel k(biweight) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482   1.59909695   .545877873   1.12054242     0.49 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.7981    -22.2    38.6 |  -0.92  0.381 |  3.67 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   2.0551     -5.5    74.9 |  -0.10  0.925 |  0.52 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.6602    -35.8   -87.8 |  -0.91  0.383 | 10.92* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25365     15.2    92.3 |   0.50  0.629 |  1.05 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8     3550     -6.3    88.7 |  -0.09  0.932 |  0.87 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18481     -9.6    96.1 |  -0.24  0.817 |  0.18 
















. *KERNEL BIWEIGHT * 
. psmatch2 T, kernel k(biweight) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 3.30378923   1.67969522   1.62409401   1.02200515     1.59 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        49          4 |        53  
-----------+----------------------+---------- 
     Total |        49        133 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_grsfixcapt avg_GDP avg_labprod, 
>  both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2707  -.50153    -62.7  -353.4 |  -0.56  0.596 |  3.42 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 1.9488   1.0132     17.7    51.0 |   0.64  0.547 |  2.10 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.9689   1.8835     22.0     0.1 |   0.31  0.765 |  0.63 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.3553   1.4976     20.4    -7.3 |   0.70  0.513 |  2.63 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.7519   2.0384     39.5  -163.5 |   1.65  0.150 |  0.29 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3715.5   3341.7     26.8    52.1 |   0.31  0.768 |  3.11 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18614    18307      8.3    96.7 |   0.24  0.817 |  0.58 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  49725    50066     -4.2    97.7 |  -0.07  0.946 |  1.13 

















. *KERNEL EPANECHNIKOV * 
. psmatch2 T, kernel k(epan) outcome (Y) pscore(PS_grwctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.47274059   1.77116297   .701577614   .224437687     3.13 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
           | psmatch2: 
 psmatch2: |   Common 
 Treatment |  support 
assignment | On suppor |     Total 
-----------+-----------+---------- 
 Untreated |       129 |       129  
   Treated |        53 |        53  
-----------+-----------+---------- 
     Total |       182 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP  d_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-.90036  -1.1838     23.1   -67.1 |   0.89  0.378 |  0.54* 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 3.1352   1.3378     34.0     5.8 |   1.75  0.082 | 26.38* 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | -1.042  -1.8875     17.2    22.2 |   0.92  0.361 |  1.82* 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 1.8134    1.031     18.7     2.1 |   0.96  0.337 | 12.43* 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 2.7872   2.3239     10.7    28.8 |   0.54  0.592 |  7.50* 
                          |                                  |               | 
 
  





A 3.8 Epanechnikov estimates (Set of six control variables -three growth-rates and 





. *KERNEL EPANECHNIKOV * 
. psmatch2 T, kernel k(epan) outcome (Y) pscore(PS_6ctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 2.14497482    1.6165416   .528433221   1.10653988     0.48 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        47          6 |        53  
-----------+----------------------+---------- 
     Total |        47        135 |       182  
 
 
. pstest d_compens d_grsfixcapt d_GDP avg_compens avg_grsfixcapt avg_GDP, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | .62595   1.6253    -18.9    47.6 |  -0.79  0.450 |  3.89 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 1.7825   1.8384     -1.1    94.9 |  -0.02  0.986 |  0.44 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | .15959   1.7422    -37.7   -98.0 |  -0.96  0.361 |  9.83* 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  26243    25439     13.9    93.0 |   0.46  0.659 |  1.04 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3461.8   3730.6    -19.3    65.5 |  -0.23  0.822 |  0.54 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18124    18502    -10.2    95.9 |  -0.25  0.806 |  0.19 
















. *KERNEL EPANECHNIKOV * 
. psmatch2 T, kernel k(epan) outcome (Y) pscore(PS_allctr) 
---------------------------------------------------------------------------------------- 
        Variable     Sample |    Treated     Controls   Difference         S.E.   T-stat 
----------------------------+----------------------------------------------------------- 
               Y  Unmatched | 2.47274059   1.54776593   .924974661   .158414056     5.84 
                        ATT | 3.30378923   1.70897436   1.59481486   1.02101514     1.56 
----------------------------+----------------------------------------------------------- 
Note: S.E. does not take into account that the propensity score is estimated. 
 
 psmatch2: |   psmatch2: Common 
 Treatment |        support 
assignment | Off suppo  On suppor |     Total 
-----------+----------------------+---------- 
 Untreated |         0        129 |       129  
   Treated |        49          4 |        53  
-----------+----------------------+---------- 
     Total |        49        133 |       182  
 
 
. pstest d_emprate d_compens d_grsfixcapt d_GDP d_labprod avg_compens avg_grsfixcapt avg_GDP  
> avg_labprod, both 
 
---------------------------------------------------------------------------------------- 
                Unmatched |       Mean               %reduct |     t-test    |  V(T)/ 
Variable          Matched | Treated Control    %bias  |bias| |    t    p>|t| |  V(C) 
--------------------------+----------------------------------+---------------+---------- 
d_emprate              U  |-.90036    -1.07     13.8         |   0.90  0.369 |  1.73* 
                       M  |-1.2707  -.52817    -60.6  -337.7 |  -0.54  0.609 |  3.37 
                          |                                  |               | 
d_compens              U  | 3.1352   1.2273     36.1         |   2.83  0.005 | 24.96* 
                       M  | 1.9488   .99714     18.0    50.1 |   0.65  0.540 |  2.10 
                          |                                  |               | 
d_grsfixcapt           U  | -1.042   .04467    -22.0         |  -1.41  0.160 |  1.48 
                       M  | 2.9689   1.8753     22.2    -0.6 |   0.32  0.758 |  0.68 
                          |                                  |               | 
d_GDP                  U  | 1.8134   1.0142     19.1         |   1.45  0.148 | 11.25* 
                       M  | 2.3553   1.5097     20.2    -5.8 |   0.69  0.517 |  2.71 
                          |                                  |               | 
d_labprod              U  | 2.7872   2.1368     15.0         |   1.15  0.254 | 11.91* 
                       M  | 3.7519   2.0791     38.5  -157.2 |   1.59  0.163 |  0.28 
                          |                                  |               | 
avg_compens            U  |  16813    28255   -197.9         | -13.43  0.000 |  2.55* 
                       M  |  24500    25694    -20.6    89.6 |  -0.65  0.540 |  0.19 
                          |                                  |               | 
avg_grsfixcapt         U  | 3325.6   4105.1    -55.8         |  -3.46  0.001 |  1.11 
                       M  | 3715.5   3336.1     27.2    51.3 |   0.31  0.764 |  3.16 
                          |                                  |               | 
avg_GDP                U  |  13366    22619   -249.2         | -13.77  0.000 |  0.29* 
                       M  |  18614    18299      8.5    96.6 |   0.25  0.812 |  0.57 
                          |                                  |               | 
avg_labprod            U  |  36934    51674   -182.2         | -11.75  0.000 |  1.60 
                       M  |  49725    49889     -2.0    98.9 |  -0.03  0.974 |  1.09 








Annex 2: Task 2 and 3 - Technical Appendix 
 
Complete results from GPS and PSM models with multiple 
intensities of the EU Funds (EU-27, 1994-2013 periods) 
 
 
A.1  Gross Value Added (GVA) Results  
 
A.1.1  Model I (GPS, longitudinal data on three periods).  
   GVA results 
 
The impacts estimates on the average annual % growth of GVA from Models I are 
summarizes in Figure A1  that illustrates the estimated dose response function and its 
derivative (the treatment effect function), respectively. 
 
Figure A1: Dose Response function and Treatment effect functions.  Estimates from    
Model I. 
Outcome: Average annual % growth of GVA  
 
Treatment level: (1=1€ /per capita /per year) 
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A.1.2  Model II: Dynamic PSM (three separate periods) 
 GVA results 
 
Table A1 highlights the GVA impact estimates from Model II (dynamic PSM with four 
categories of EU Fund –EUF- intensities) implemented with a radius ((=0.05) 
matching specification.  The global ATT impact estimates are obtained as weighted 
average of the local ATTs estimated separately for each of the three periods 1994-99; 
2000-06 and 2007-13 (capped at the year 2010 for the EUF and the year 2011 for the 












Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
-0.0057 0.0055 60 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
-0.0035 0.0029 69 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
-0.0066*** 0.0022 153 
 (*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates.  
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
The ATTs estimates of Table A1 are in terms of percentage points (0.01= 1 p.p.) and 
indicate the additional annual % growth of per-capita GVA induced in a NUTS2 region 
by receiving a total intensity of EUF belonging to Cats. (IV), (III) or (II) versus a 
counterfactual scenario of receiving the low intensity of Cat. (I). None of the impact 
estimates reach statistical significance levels, except for the negative impact  of Cat.II 
(-0.67 p.p., significant at the 10% level). 
 
Table A2 highlights the GVA impact estimates from Model II (dynamic PSM with four 
categories of EUF intensities) implemented with a Nearest Neighbour (with caliper) 
matching specification. 
 




Table A3 highlights the GVA impact estimates from Model II (dynamic PSM with four 





Table A2  
 







Cat.(IV):  112.50€  <[Avg. annual 
per-capita EU Funds] 
-0.0057 0.0055 60 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
-0.0035 0.0029 69 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
-0.0066*** 0.0022 153 
 (*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 















Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
-0.0065 0.0039 96 
Cat.(III): 35.19€ <[Avg. annual per-capita 
EU Funds]≤ 112.50€  
-0.0046* 0.0025 66 
Cat.(II): 19.99€ <[Avg. annual per-capita 
EU Funds]≤ 35.19€  
-0.0063*** 0.0028 128 
 (*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
 
A.1.3  Model III: GPS, whole 1994-2010 period 
  GVA results 
 
Figure A2 summarizes the GVA results from Model III that implements a GPS 
estimator on aggregated data for the whole 1994-2010 period of EUF. The right 
portion of Figure A2 shows the dose response function, while the left part illustrates 
the treatment effect function. 
  





Figure A2: Dose Response function and Treatment effect functions.  Estimates from 
Model III. 
Outcome: Average annual % growth of GVA  
 
Treatment level: (1=1€ per capita, total value for the 1994-2010 period) 
Outcome: Avg. annual % growth of per capita Gross Value Added (0.1 = 1%) 
 
 
A.1.4   Model IV: PSM with categorical treatment intensities, whole 1994-2010 period 
          GVA results 
 
Tables A4-A6 summarize the results from  Model IV, the PSM estimator with four 
categorical treatment intensities implemented over the whole (undivided) 1994-2010 
period. For these PSM models, the four categories of EUF intensities are based on the 
distribution of the total per-capita amount of the EUF received over the entire 1994-
2010 period. This distribution is as follows: 
 I Quartile (low intensity) = per-capita amount of EUF below 370.90€ (mean 
value  of cat. I = 261.54€) 
 II Quartile (medium-low intensity) = per-capita amount of EUF  between 
370.90€ and 613.65€ 
 III Quartile (medium-high intensity) = per-capita amount of EUF  between 
613.65€ and 1235.34€ 
 IV Quartile (high intensity) = Avg. annual per-capita EUF in the period above 
1235.34€ 
 
Table A4 presents the results from the radius matching specification (=0.05), Table 
A5 the results from the Nearest Neighbour matching (with caliper =0.05) and Table 
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Cat.(IV):  1235.34€  <[tot. per-capita EU 
Funds in 1994-10] 
0.003601* 0.002499 28 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.01386*** 0.00417 53 
Cat.(II): 370.90€ <[Avg. annual per-capita 
EU Funds]≤ 613.65€  
-0.00236*** 0.0019 65 
(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  















Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.00484*** 0.00229 28 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.01467*** 0.002612 53 
Cat.(II): 370.90€ <[Avg. annual per-




(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  














Cat.(IV):  1235.34€  <[tot. per-capita 




Cat.(III): 613.65€ <[Tot. per-capita EU 




Cat.(II): 370.90€ <[Avg. annual per-
capita EU Funds]≤ 613.65€  
-0.002362   65 
(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  





A2.  Gross-Fixed-Capital–Formation (GFCF) Results  
 
 
A.2.1  Model I: GPS, longitudinal data on three periods.  
GFCF results 
 
The impacts estimates on the average annual % growth of GFCF from Models I are 
summarizes in Figure A3  that illustrates the estimated dose response function and its 
derivative (the treatment effect function), respectively. 
 
Figure A3:  Dose Response function and Treatment effect functions.  
Estimates from Model I. 
Outcome: Average annual % growth of GFCF  
 
Treatment level: (1=1€ /per capita /per year) 
Outcome: Avg. annual % growth of per capita Gross Fixed Capital Form. (0.1 = 1%) 
 
 
A.2.2  Model II: Dynamic PSM (three separate periods) 
 GFCF results 
 
Table A7 highlights the GFCF impact estimates from Model II (dynamic PSM with four 
categories of EUF intensities) implemented with a radius ((=0.05) matching 
specification.  The global ATT impact estimates are obtained as weighted average of 
the local ATTs impacts of the three periods 1994-99; 2000-06 and 2007-13 (capped at 
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Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
-0.0143 0.0095 60 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
-0.0059 0.0052 69 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
-0.0052 0.008 153 
(*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
The ATTs estimates of Table A7 are in terms of percentage points (0.01= 1 p.p.) and 
indicate the additional annual % growth of per-capita GFCF induced in a NUTS2 region 
by receiving a total intensity of EU funds belonging to Cats. (IV), (III) or (II) versus a 
counterfactual scenario of receiving the low intensity of Cat. (I).  
 
Table A8 highlights the GFCF impact implemented with a Nearest Neighbour (with 
caliper) Matching, while Table A9 summarizes the estimates from a Kernel matching 
(Epanechnikov)  specification. 
 
  














Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
-0.0164 0.012 60 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
-0.0102** 0.0046 69 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
-0.0050 0.0064 153 
(*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
  















Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
-0.0100 0.0094 69 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
-0.0065 0.0047 66 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
-0.0104* 0.0056 128 
 (*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  





A.2.3  Model III: GPS, whole 1994-2010 period 
  GFCF results 
 
Figure A4 summarizes the GFCF results from Model III that implements a GPS 
estimator on the aggregated data for the whole 1994-2010 period. The right portion of 
Figure A4 shows the dose response function, while the left part illustrates the 
treatment effect function. 
 
Figure A4:  Dose Response function and Treatment effect functions. 
Estimates from Model III. 
Outcome: Average annual % growth of GFCF  
 
Treatment level: (1=1€ per capita, total value for the 1994-2010 period) 




A.2.4  Model IV: PSM with categorical treatment intensities, whole 1994-2010 period 
GFCF results 
 
Tables A10-A12 summarize the results from  Model IV, the PSM estimator with four 
categorical treatment intensities implemented over the whole (undivided) 1994-2010 
period of EUF payments. For these PSM models, the four categories of intensities of 
the EUF are based on the distribution of the total per-capita amount of the EUF 
received over the entire 1994-2010 period. This distribution is as follows: 
 I Quartile (low intensity) = per-capita amount of EUF below 370.90€ (mean 
value  of cat. I = 261.54€) 
 II Quartile (medium-low intensity) = per-capita amount of EUF  between 
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 III Quartile (medium-high intensity) = per-capita amount of EUF  between 
613.65€ and 1235.34€ 
 IV Quartile (high intensity) = Avg. annual per-capita EUF in the period above 
1235.34€ 
 
Table A10 presents the results from the radius matching specification (=0.05), Table 
A11 the results from the Nearest Neighbour matching (with caliper =0.05) and Table 












Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.00242 0.00927 28 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.00785 0.0166 53 
Cat.(II): 370.90€ <[Avg. annual per-
capita EU Funds]≤ 613.65€  
-0.00571 0.0063 65 
(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  














Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.00794* 0.005577 28 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.00857 0.00748 53 
Cat.(II): 370.90€ <[Avg. annual per-
capita EU Funds]≤ 613.65€  
-0.00488* 0.002978 65 
(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
  















Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.00304 0.00955 29 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.0111 0.01754 57 
Cat.(II): 370.90€ <[Avg. annual per-
capita EU Funds]≤ 613.65€  
-0.00564 0.00624 65 
(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  





A.3 Employment Rate (EMPRT) Results 
 
A.3.1  Model I: GPS, longitudinal data on three periods.  
    EMPRT results 
 
The impacts estimates on the average annual change of EMPRT from Models I are 
summarizes in Figure A5  that illustrates the estimated dose response function and its 
derivative (the treatment effect function), respectively. 
 
Figure A5: Dose Response function and Treatment effect functions.  Estimates from 
Model I. 
Outcome: Average annual  change of EMPRT 
 
Treatment level: (1=1€ /per capita /per year) 




A.3.2  Model II: Dynamic PSM (three separate periods) 
    EMPRT results 
 
Table A13 highlights the EMPRT impact estimates from Model II (dynamic PSM with 
four categories of EUF intensities) implemented with a radius ((=0.05) matching 
specification.  The global ATT impact estimates are obtained as weighted average of 
the local ATTs estimated separately for each of the three periods 1994-99; 2000-06 
































0 200 400 600
Treatment level
Dose Response Low bound
Upper bound
Confidence Bounds at .95 % level































































0 200 400 600
Treatment level
Treatment Effect Low bound
Upper bound
Confidence Bounds at .95 % level
Dose response function = Linear prediction
Treatment Effect Function














Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
0.0017 0.0011 60 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
0.0020*** 0.0007 69 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
0.0012 0.0015 153 
(*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
The ATTs estimates of Table A13 are in terms of percentage points (0.01= 1 p.p.) and 
indicate the change in the EMPRT of a NUTS2 region in which the intensity of the total 
EUF received in the whole period 1994-2010 belongs to Cats. (IV), (III) or (II) versus 
a counterfactual scenario of receiving EUF with the low intensity of Cat. (I).  
 
Table A14 highlights the EMPRT impact  estimates obtained through  a Nearest 
Neighbour (with caliper) Matching, while Table A15 summarizes the estimates from a 
Kernel matching (Epanechnikov)  specification. 
 
  














Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
0.0015 0.0013 60 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
0.0015*** 0.0006 69 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
0.0009 0.0013 153 
(*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference 
for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  














Cat.(IV):  112.50€  <[Avg. annual per-
capita EU Funds] 
0.0021 0.0011 69 
Cat.(III): 35.19€ <[Avg. annual per-
capita EU Funds]≤ 112.50€  
0.0018 0.0006 86 
Cat.(II): 19.99€ <[Avg. annual per-
capita EU Funds]≤ 35.19€  
0.0003 0.0007 128 
(*) Cat. I [Avg. annual per-capita EU Funds]≤ 19.99€  is the baseline reference for all ATTs estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 









A.3.3  Model III: GPS, whole 1994-2010 period 
     EMPRT results 
 
Figure A6 summarizes the EMPRT results from Model III that implements a GPS 
estimator on the aggregated data for the whole 1994-2010 period of EUF payments. 
The right portion of Figure A6 shows the dose response function, while the left part 
illustrates the treatment effect function. 
 
Figure A6: Dose Response function and Treatment effect functions.  Estimates from 
Model III. 
Outcome: Average annual % growth of GFCF  
 
Treatment level: (1=1€ per capita, total value for the 1994-2010 period) 
Outcome: Avg. annual change of Employment rate (0.1 = 1 p.p.) 
 
 
A.3.4  Model IV: PSM with categorical treatment intensities, whole 1994-2010 period 
 EMPRT results 
 
Tables A16-A18 summarize the results from  Model IV, the PSM estimator with four 
categorical treatment intensities implemented over the whole (undivided) 1994-2010 
period of EUF payments. For these PSM models, the four categories of EUF intensities 
are based on the distribution of the total per-capita amount of the EUF received over 
the entire 1994-2010 period. This distribution is as follows: 
 I Quartile (low intensity) = per-capita amount of EU Funds below 370.90€ 
(mean value  of cat. I = 261.54€) 
 II Quartile (medium-low intensity) = per-capita amount of EU Funds  
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 III Quartile (medium-high intensity) = per-capita amount of EU Funds  
between 613.65€ and 1235.34€ 
 IV Quartile (high intensity) = Avg. annual per-capita EU Funds in the period 
above 1235.34€ 
 
Table A16 presents the results from the radius matching specification (=0.05), Table 
A17 the results from the Nearest Neighbour matching (with caliper =0.05) and Table 












Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.00167** 0.000829 28 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.000286 0.00134 53 
Cat.(II): 370.90€ <[Avg. annual per-
capita EU Funds]≤ 613.65€  
-0.00079* 0.00057 65 
 (*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  














Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.000553 0.000752 28 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.000586 0.00565 53 
Cat.(II): 370.90€ <[Avg. annual per-




(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
***=statistical significance at 0.01 level 
 
  














Cat.(IV):  1235.34€  <[tot. per-capita 
EU Funds in 1994-10] 
0.001594* 0.000872 29 
Cat.(III): 613.65€ <[Tot. per-capita EU 
Funds  in 1994-10]≤ 1235.34€  
0.000215 0.00144 57 
Cat.(II): 370.90€ <[Avg. annual per-
capita EU Funds]≤ 613.65€  
-0.000791* 0.000566 65 
(*) Cat. I [Avg. tot. per-capita EU Funds 1994-10]≤ 370.90€  is the baseline reference for all ATTs 
estimates 
*=statistical significance at 0.10 level  
**=statistical significance at 0.05 level 
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• one copy: 
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• more than one copy or posters/maps: 
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from the delegations in non-EU countries 
(http://eeas.europa.eu/delegations/index_en.htm);  
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